Page last updated: 2024-08-23

epirubicin and Local Neoplasm Recurrence

epirubicin has been researched along with Local Neoplasm Recurrence in 377 studies

Research

Studies (377)

Timeframe	Studies, this research(%)	All Research%
pre-1990	13 (3.45)	18.7374
1990's	117 (31.03)	18.2507
2000's	115 (30.50)	29.6817
2010's	121 (32.10)	24.3611
2020's	11 (2.92)	2.80

Authors

Authors	Studies
Honda, T; Imai, N; Ishigami, M; Ishizu, Y; Ito, T; Yamamoto, K; Yokoyama, S	1
Niu, X; Wang, T; Zhong, B	1
Budaya, TN; Daryanto, B; Purnomo, AF; Seputra, KP	1
He, X; Hou, Z; Li, J; Meng, L; Qin, B; Wang, H; Wang, Z; Wei, Y; Xue, X; Zhang, X; Zhang, Z	1
Brummelhuis, ISG; Crezee, J; Witjes, JA	1
Ambite, I; Babjuk, M; Cavalera, M; Chaudhuri, A; Esmaeili, P; Hien, TT; Sabari, S; Svanborg, C; Wan, MLY	1
El-Kappany, H; El-Nahas, AR; El-Shabrawy, M; Harraz, AM; Osman, Y	1
Diao, WL; Guo, HQ; Wang, TW; Yang, R; Yuan, H; Zhao, XZ	1
Broeks, A; Cimino-Mathews, A; Daletzakis, A; de Boo, L; Hooijberg, E; Horlings, HM; Kok, M; Linn, S; Loncova, Z; Lubeck, Y; Opdam, M; Rieder, D; Sanders, J; Sobral-Leite, M; Trajanoski, Z; van de Vijver, K; van der Wiel, R; van Rossum, A; van Tinteren, H; Vollebergh, M	1
Chang, ED; Kim, JS; Kim, YS; Lee, DS; Na, SJ; Whang, IY; Won, HS	1
Adachi, M; Kamiya, A; Koshiishi, H; Matsunaga, H; Ogawa, N; Sasaki, M; Sugimoto, H; Yoshimura, T	1
Bergan, R; Cao, M; Liu, B; Liu, Y; Luoh, SW; Mori, M; Zhang, X; Zhang, Z	1
Hou, E; Lai, L; Lu, Y; Meng, W; Tan, Z; Wei, J; Zhang, X	1
Adriaenssens, E; Angrand, PO; Bidan, N; Chopin, V; Lagadec, C; Le Bourhis, X; Meignan, S; Toillon, RA; Völkel, P; Winter, M	1
Chen, CS; Cheng, CL; Chiu, KY; Ho, HC; Hung, SC; Li, JR; Ou, YC; Wang, SS; Yang, CK	1
Chen, L; Cui, XG; Gao, Y; Huang, H; Pan, XW; Wang, LH; Xu, DF; Yang, QW	1
Anderegg, MCJ; Gisbertz, SS; Hulshof, MCCM; Los, M; Mohammed, NH; Ruurda, JP; van Berge Henegouwen, MI; van der Sluis, PC; van Hillegersberg, R; van Laarhoven, HWM; van Vulpen, M; Wiezer, MJ	1
Chen, G; Peng, Z; Tao, W; Wang, Z; Ying, Y; Zhang, D; Zhang, J; Zhu, H	1
Bonnefoi, H; Breton-Callu, C; Cameron, D; Gillon, P; Slaets, L; Touati, N	1
Denkert, C; Forstbauer, H; Hoffmann, G; Karn, T; Kohls, A; Köhne, CH; Linn, SC; Loibl, S; Marmé, F; Möbus, VJ; Nekljudova, V; Schem, C; Schmatloch, S; Schouten, PC; Solbach, C; Thomssen, C; van Rossum, AGJ; von Minckwitz, G; Weber, KE	1
Liu, Y; Shang, D; Song, B	1
Alberts, SR; Berg, DJ; Bjarnason, GA; Ciombor, K; Dragovich, T; Enzinger, PC; Fuchs, CS; Goldberg, RM; Gunderson, LL; Haller, DG; Ilson, D; Mamon, HJ; Mayer, RJ; Meyerhardt, J; Niedzwiecki, D; O'Reilly, E; Swanson, RS; Tepper, JE; Venook, AP; Willett, CG; Ye, X	1
Joensuu, H; Lindman, H	1
Altundag, K	1
Cozar-Olmo, JM; Fernandez-Gomez, JM; Juárez, A; Martínez-Piñeiro, L; Palou, J; Unda-Urzaiz, M	1
Chen, J; Chen, L; Fan, W; Huang, B; Qiu, S; Yao, Z; Zheng, J	1
Charlson, J	1
Ali-El-Dein, B; Bazeed, MA; El-Assmy, AM; Elsawy, AA	1
Chen, J; Chen, L; Fan, W; Huang, B; Lin, H; Qiu, S; Wang, H; Yao, Z; Zheng, J	1
Anthoney, A; Germetaki, T; Kamposioras, K; Kordatou, Z; Mansoor, W; Nasralla, M; Owen-Holt, V; Papaxoinis, G; Stamatopoulou, S; Weaver, JMJ	1
Fujii, S; Ito, H; Omoto, H; Takada, M; Yamashita, S	1
Chen, W; Cui, W; Fan, W; Li, J; Lian, F; Liu, Y; Shen, L; Wang, Y; Zhao, Y	1
Hidaka, H; Inoue, T; Koizumi, W; Kubota, K; Nakazawa, T; Onoue, M; Shibuya, A; Tanaka, Y; Uojima, H; Wada, N	1
Hamamoto, S; Hamuro, M; Jogo, A; Kageyama, K; Miki, Y; Minami, T; Nakano, MM; Nishida, N; Sohgawa, E; Yamamoto, A	1
Chen, J; Chen, L; Li, J; Qiu, S; Wang, Y; Yang, J; Yao, Z	1
Fujita, Y; Fukuda, K; Fuwa, S; Iizuka, Y; Ishii, N; Matsuda, M; Omata, F; Saida, Y; Suzuki, S; Uemura, M	1
Cai, RG; Li, Q; Wang, JY; Wang, X; Xu, BH; Xu, XZ; Yin, Y; Yuan, P; Zhang, BL; Zhang, P	1
Chen, CS; Chiou, HY; Hung, CS; Pan, CK; Tai, CJ; Wu, CH	1
Kuranishi, F; Ohno, T	1
Chen, Q; Fan, L; Jiang, J; Qi, X; Wang, S; Yang, X; Zhang, Y	1
Alexander, C; Connors, JM; Gascoyne, RD; Hamilton, SN; Tan, K; Wai, ES	1
Mirza, A; Pritchard, S; Welch, I	1
Bailey, IS; Byrne, JP; Curtis, NJ; Kelly, JJ; Noble, F; Underwood, TJ	1
Agterof, M; Borel-Rinkes, I; Lolkema, MP; Overkleeft, E; Reerink, O; Schipper, M; Siersema, P; Ubink, I; van der Sluis, P; van Hillegersberg, R; Vleggaar, F; Voest, E; Wijrdeman, H	1
Bailey, IS; Bateman, AC; Bateman, AR; Byrne, JP; Iveson, TJ; Kelly, JJ; Noble, F; Nolan, L; Rees, CN; Sharland, DM; Underwood, TJ	1
Cao, J; Huang, XE; Liu, J; Lu, YY; Wu, XY	1
Goos, M; Illerhaus, G; Makowiec, F; Ruf, C; Ruf, G; Thomusch, O	1
Blaskowsky, LS; Enzinger, PZ; Hong, TS; Kwak, EL; Mamon, HJ; Mullen, JT; Ryan, DP; Schoenfeld, JD; Wo, JY	1
Abdel-Wahab, M; Abubaker, S; Afiane, M; Benjaafar, N; Bourque, JM; Chansilpa, Y; El-Gantiry, M; Elattar, I; Levendag, P; Rosenblatt, E; Vikram, B	1
Hayashi, N; Kajiura, Y; Matsuda, N; Nakamura, S; Ohde, S; Suzuki, K; Tsunoda, H; Yagata, H; Yamauchi, H; Yoshida, A	1
Arends, TJ; van der Heijden, AG; Witjes, JA	1
Deo, SV; Gogia, A; Mohanti, BK; Raina, V; Sharma, DN; Shukla, NK	1
Chen, CC; Jiang, RS; Liang, KL; Lin, JC; Lin, PJ; Liu, YC; Shih, YT; Twu, CW; Wang, WY; Wu, CT	1
Kalachand, R; King, S; Mongan, AM; Muldoon, C; O'Byrne, K; O'Farrell, NJ; Power, D; Ravi, N; Reynolds, JV	1
Brausi, MA; de Reijke, TM; Kirkels, WJ; Oddens, JR; Oosterlinck, W; Prescott, S; Sylvester, RJ; van Andel, G; van de Beek, C; Witjes, JA	1
Chen, M; Han, XM; Li, T; Li, WC; Liu, SC; Xing, Y	1
Chen, WG; Chen, XS; Huang, O; Jiang, M; Li, YF; Shen, KW; Wu, JY	1
Amarillo, I; Fisher, SI; Rashidi, A	1
Deng, Y; Jiao, J; Li, J; Wang, C; Yang, Q; Zhang, T	1
Dong, YG; Jiang, XM; Li, YY; Ma, YB; Xu, G	1
Borani, N; Karalök, MA; Keskin, HL; Köse, MF; Özgül, N; Tulunay, HG; Turan, AT; Üreyen, I	1
Decaestecker, K; Lumen, N; Oosterlinck, W; Ringoir, A	1
Li, Y; Shang, YM; Yang, Y; Zheng, H	1
Bonanno, L; Canova, F; Carli, P; Conte, P; Favaretto, A; Pasello, G; Polo, V; Urso, L; Zago, G	1
Lau, WY; Lei, Z; Li, J; Shen, F; Si, A; Wan, X; Wang, K; Wang, Q; Wang, Y; Wu, D; Wu, M; Xia, Y; Yan, Z	1
Ali-El-Dein, B; Babjuk, M; Birtle, A; De Nunzio, C; Gudjonsson, S; Holmang, S; Inman, BA; Kaasinen, E; N'Dow, J; Oddens, JR; Okamura, K; Oosterlinck, W; Solsona, E; Sydes, MR; Sylvester, RJ; Tatar, CA	1
Kato, T; Komiya, A; Kondo, F; Nomura, K; Wakisaka, M	1
Hashimoto, Y; Hatakeyama, S; Hosogoe, S; Imai, A; Koie, T; Mori, K; Ohyama, C; Tobisawa, Y; Yamamoto, H; Yoneyama, T	1
Brisse, H; Fasola, S; Mosseri, V; Orbach, D; Winter, S	1
Aftimos, P; Ameye, L; Beauduin, M; Bejarano Hernández, S; Cornez, N; de Azambuja, E; Delhaye, F; Diaz, M; Focan, C; Lemort, M; Paesmans, M; Piccart-Gebhart, M; Shih-Li, C; Suter, T; Vandenbossche, S; Vindevoghel, A	1
Bottelli, S; Casali, PG; Comandone, A; De Paoli, A; De Sanctis, R; Ferrari, S; Gronchi, A; Libertini, M; Lopez-Pousa, A; Martin Broto, J; Palassini, E; Palmerini, E; Picci, P; Quagliuolo, V; Sangalli, C; Verderio, P	1
Au, HJ; Bies, RR; Carandang, D; Cass, CE; Clemons, M; Damaraju, S; Damaraju, VL; Hanson, J; Joy, AA; King, K; Koski, S; Kuzma, M; Mackey, JR; Pituskin, E; Prado, CM; Sawyer, MB; Scarfe, AG; Smylie, M; Tonkin, K; Vos, LJ	1
Biard, L; Cuvier, C; de Cremoux, P; de Roquancourt, A; Espié, M; Giacchetti, S; Groheux, D; Hindié, E; Merlet, P; Resche-Rigon, M; Teixeira, L; Vercellino, L	1
Arai, Y; Doi, M; Hashimoto, K; Kojima, Y; Mimura, H; Nakajima, Y; Tsugawa, K	1
Ba, DN; Chao, TY; Hou, MF; Kim, SB; Sayeed, A; Shah, MA; Shen, ZZ; Thuan, TV; Villalon, AH; Yau, TK	1
Hu, YJ; Ju, RJ; Liu, L; Lu, WL; Mu, LM; Wu, JS; Xie, HJ; Yan, Y; Zeng, F; Zhao, Y	1
Cosio, S; Fanucchi, A; Gadducci, A; Lanfredini, N; Menichetti, A; Notarnicola, M	1
Cheon, GJ; Chung, JK; Kang, KW; Kim, EE; Kim, YI; Lee, DS; Moon, WK; Paeng, JC; Yoon, HJ	1
Arima, N; Fukunaga, A; Hyuga, M; Iwasaki, M; Kishimoto, W; Maesako, Y; Nakae, Y	1
Alunni-Fabbroni, M; Andergassen, U; Fasching, P; Fehm, T; Friedl, TW; Hecker, N; Hepp, P; Jäger, B; Janni, W; Lorenz, R; Rack, B; Schneeweiss, A; Trapp, E	1
Cui, H; Jiang, R; Li, X; Lin, X; Liu, C; Tao, R; Tian, S; Zhuang, H; Zhuo, C	1
Colombel, MC	1
Anderson, H; Bengtsson, NO; Bergh, J; Brandberg, Y; Carlsson, L; Egle, D; Fornander, T; Foukakis, T; Gnant, M; Greil, R; Hellström, M; Johansson, H; Karlsson, E; Loibl, S; Malmström, P; Mlineritsch, B; Möbus, V; Schmatloch, S; Singer, CF; Steger, G; Untch, M; von Minckwitz, G; Wallberg, B	1
Boorjian, SA; Lu, DD; Raman, JD	1
Collignon, J; Delvenne, P; Donneau, AF; Feyereisen, E; Foidart, P; Gofflot, S; Jerusalem, G; Lienard, M; Noël, A; Schroeder, H; Somja, J; Sounni, NE; Truong, A; Yip, C	1
Fors, M; Grenman, S; Kuoppala, T; Lehtovirta, P; Luukkaala, T; Mäenpää, J; Puistola, U; Salmi, T; Sipilä, P; Tomas, E	1
Arnedos, M; Ashley, S; Johnston, S; Nerurkar, A; Popat, S; Sirohi, B; Smith, IE; Walsh, G	1
Chu, SC; Kao, RH; Li, CC; Wang, TF; Yao, CY	1
Engeler, DS; Hobi, C; Müller, J; Neyer, M; Schmid, HP; Wyler, S	1
Andersen, PK; Cortese, G; Nielsen, D; Nielsen, G; Ryberg, M; Skovsgaard, T	1
Acaia, B; Azim, HA; Bonazzi, C; Calabrese, L; Cinieri, S; Gadducci, A; Galimberti, V; Gentilini, O; Goldhirsch, A; Intra, M; Locatelli, M; Peccatori, FA; Rossi, P; Scarfone, G	1
Hamada, Y; Horikoshi, N; Ichinose, I; Ikeda, T; Ishikawa, E; Kobayashi, S; Mitsuyama, S; Tamura, K	1
Choi, IK; Kim, AR; Kim, JS; Kim, YH; Koo, BH; Lee, JB; Oh, SC; Park, KH; Seo, JH; Shin, SW; Sung, HJ	1
Oosterlinck, W; Sylvester, R	1
Cai, RG; Li, Q; Wang, JY; Wu, WH; Xu, BH; Yuan, P; Zhang, P; Zhao, LM; Zhou, AP	1
Azuma, H; Katsuoka, Y; Nishida, T; Nomi, H; Segawa, N; Takahara, K	1
Gou, HY; Han, JS; Li, H; Li, SM; Qiao, J; Yang, R	1
Chang, JW; Chen, CH; Lin, CM; Tsao, TC	1
Duchek, M; Hellsten, S; Hellström, P; Jahnson, S; Johansson, R; Malmström, PU; Mestad, O	1
Babjuk, M	1
Alanko, T; Asola, R; Auvinen, P; Bono, P; Helle, L; Huusko, M; Ingalsuo, S; Isola, J; Joensuu, H; Jyrkkiö, S; Kataja, V; Kellokumpu-Lehtinen, PL; Kokko, R; Leinonen, H; Leinonen, M; Möykkynen, K; Pajunen, M; Salminen, T; Turpeenniemi-Hujanen, T; Utriainen, T	1
Chou, YH; Huang, CH; Ke, HL; Li, CC; Wu, WJ; Yang, YH	1
Nieder, AM	1
Choi, IK; Jung, KY; Kim, CY; Kim, JS; Kim, YH; Lee, NJ; Oh, SC; Park, KH; Park, Y; Park, YJ; Seo, HY; Seo, JH; Shin, SW	1
Kumon, H; Miyaji, Y; Nasu, Y; Saegusa, M; Saika, T; Takeda, K; Tsushima, T	1
Allegro, R; Altieri, V; Battaglia, M; Di Lallo, A; Falsaperla, M; Melloni, D; Morgia, G; Ruggiero, G; Salzano, L; Sblendorio, D; Serretta, V; Zito, A	1
Chen, MK; Han, H; Hou, GL; Li, YH; Liu, ZW; Lu, KS; Qin, ZK; Tu, H; Yang, ZW; Yao, K; Ye, YL; Zhang, XQ; Zhang, ZL; Zhou, FJ	1
Hama, Y; Nakagawa, K	1
Altundag, K; Arslan, C; Dogan, E; Kara, O; Ozdemir, E	1
Améri, A; Béroud, R; Cret, C; Koumakis, E; Meppiel, E; Stefanizzi, S	1
Ben Salah, H; Boudawara, T; Daoud, J; Frikha, M; Gargouri, R; Ghorbel, A; Ghorbel, L; Karray, H; Khabir, A; Toumi, N	1
Egawa-Takata, T; Enomoto, T; Fujita, M; Kimura, T; Matsuzaki, S; Miyake, T; Miyatake, T; Ueda, Y; Yokoyama, T; Yoshino, K	1
Ikoma, A; Kawai, N; Minamiguchi, H; Nakai, M; Nakata, K; Sahara, S; Sato, M; Sawa, N; Shirai, S; Sonomura, T; Takasaka, I	1
Abrous-Anane, S; Bollet, MA; Campana, F; Daveau, C; Dendale, R; Fourquet, A; Gautier, C; Kirova, YM; Pierga, JY; Reyal, F; Savignoni, A	2
Arcuri, C; Arisi, E; Caffo, O; Caldara, A; Ferro, A; Galligioni, E; Griso, C; Murgia, V; Scalone, S; Sorio, R	1
Higashi, S; Ikushima, I; Iryo, Y; Ishii, A; Ota, Y; Seguchi, K; Shima, M	1
Drewa, T; Gurtowska, N; Kloskowski, T	1
Akaza, H; Hinotsu, S; Koga, H; Kume, H; Nagamori, S; Naito, S; Nasu, Y; Noguchi, S; Ozono, S; Samma, S; Sumiyoshi, Y; Tanaka, Y; Terai, A; Tomita, Y; Tsushima, T; Uemura, H; Yamaguchi, A	1
Chu, P; DU, XL; Li, DP; Liu, NF; Lu, CH; Sheng, XG; Zhou, CX	1
Barbour, A; Gotley, DC; Hirst, J; Smithers, BM; Thomas, J	1
Arriagada, R; Bourgier, C; Dunant, A; Heymann, S; Marsiglia, H; Mathieu, MC; Pessoa, EL; Spielmann, M; Uzan, C	1
Kajiura, Y; Yagata, H; Yamauchi, H	1
Brandberg, Y; Einbeigi, Z; Hatschek, T; Johansson, H; Svensson, H	1
Altomare, E; Bargellini, I; Bartolozzi, C; Bertini, M; Bertoni, M; Bozzi, E; Bresci, G; Capria, A; Cicorelli, A; Cioni, R; Federici, G; Ginanni, B; Metrangolo, S; Parisi, G; Romano, A; Sacco, R; Tumino, E	1
Botti, C; Carpino, A; Colucci, G; Di Lauro, L; Filippelli, G; Giannarelli, D; Giotta, F; Latorre, A; Lopez, M; Perri, P; Pizzuti, L; Sergi, D; Vici, P; Vizza, E	1
Jiang, L; Kwong, J; Shang, PF; Tian, J; Tian, JQ; Wang, ZP; Yang, K; Yue, ZJ	1
Hayami, S; Ozawa, S; Shigekawa, Y; Tani, M; Uchiyama, K; Ueno, M; Yamaue, H	1
Andrieu, JM; Bats, AS; Eme, D; Hofmann, H; Huchon, C; Le Frere-Belda, MA; Lecuru, F; Levy, E; Medioni, J; Oudard, S	1
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Imai, N; Kawamura, Y; Kobayashi, M; Kumada, H; Saitoh, S; Seko, Y; Sezaki, H; Suzuki, F; Suzuki, Y	1
Arnould, L; Coudert, B; Favier, L; Fumoleau, P; Ghiringhelli, F; Ladoire, S; Pfitzenmeyer, P; Quipourt, V; Rambach, L	1
Caris, CT; Hendricksen, K; Janzing-Pastors, MH; Lammers, RJ; Witjes, JA; Witjes, WP	1
Akazawa, K; Ishihara, H; Kim, SJ; Matsushima, T; Nakayama, S; Noguchi, S; Shibayama, M; Shimazu, K; Tamaki, Y; Torikoshi, Y; Tsukamoto, F	1
Bozonnat, MC; Chakra, M; Gervais, R; Jacot, W; Molinier, O; Pujol, JL; Quantin, X	1
Cao, M; Chen, HG; Ma, CK; Ma, J; Xue, W	1
Bafaloukos, D; Batistatou, A; Bobos, M; Briasoulis, E; Christodoulou, C; Dafni, U; Dimopoulos, MA; Eleftheraki, AG; Fountzilas, G; Gogas, H; Kalofonos, HP; Karanikiotis, C; Karina, M; Kosmidis, P; Markopoulos, C; Papadimitriou, C; Papakostas, P; Pectasides, D; Samantas, E; Stathopoulos, GP; Timotheadou, E	1
Hashimoto, M; Matsui, O; Miyayama, S; Shibata, Y; Toshima, F; Tsuji, K; Yamashiro, M; Yoshida, M	1
Aprile, G; Balzano, G; Cereda, S; Di Carlo, V; Di Muzio, N; Fugazza, C; Magli, A; Milandri, C; Passoni, P; Reni, M; Rognone, A; Saletti, P; Tronconi, MC; Villa, E; Zerbi, A	1
Hirohara, J; Ikeda, H; Kaibori, M; Kariya, S; Koreeda, C; Kwon, AH; Nakahashi, Y; Okazaki, K; Sawada, S; Seki, T; Tanigawa, N	1
Kang, WM; Ma, ZQ; Wang, J; Yu, JC	1
Imholz, ALT; Laddach, N; Lips, EH; Mulder, L; Oonk, AMM; Rodenhuis, S; Savola, SP; Smits, MM; van Rijn, C; Wesseling, J	1
Dalenc, F; Filleron, T; Fumoleau, P; Kerbrat, P; Kramar, A; Martin, AL; Roché, H; Spielmann, M	1
Hatamaru, K; Henmi, S; Inuzuka, T; Kimura, T; Kita, R; Matsuda, F; Nakajima, J; Nasu, A; Nishikawa, H; Osaki, Y; Saito, S; Sakamoto, A; Takeda, H	1
Casali, PG; Comandone, A; De Paoli, A; Dei Tos, AP; Ferrari, S; Ferraro, A; Fiore, M; Frustaci, S; Grignani, G; Gronchi, A; Majò, J; Martin, J; Palassini, E; Picci, P; Pizzamiglio, S; Quagliuolo, V; Stacchiotti, S; Tendero, O; Verderio, P	1
Bafaloukos, D; Christodoulou, C; Fountzilas, G; Gogas, H; Kalogeras, KT; Koutras, AK; Kouvatseas, G; Kronenwett, R; Linardou, H; Pectasides, D; Samantas, E; Wirtz, RM; Zagouri, F	1
Chen, J; Huan, Y; Jia, Q; Jiang, W; Wang, L; Wei, M; Xu, J; Zheng, M	1
Allegro, R; Altieri, V; Carrieri, G; Di Lallo, A; Morgia, G; Serretta, V	1
Dar, AR; Erickson, AL; Inculet, RI; Malthaner, RA; Palma, DA; Pierce, G; Rodrigues, GB; Yaremko, BP; Yu, E	1
Inaji, H; Kasugai, T; Komoike, Y; Koyama, H; Motomura, K	1
Kaasinen, E; Liukkonen, T; Raitanen, M; Rajala, P; Rintala, E	1
Inaji, H; Kasugai, T; Koizumi, M; Komoike, Y; Koyama, H; Motomura, K; Nose, T; Sawai, Y	1
Achard, JL; Charrier, S; Chollet, P; Cure, H; Dauplat, J; De Latour, M; Feillel, V; Ferriere, JP; Le Bouedec, G; Leduc, B; Van Praagh, I	1
Baranzelli, MC; Barnouin, L; Bay, JO; Bui, NB; Chevreau, C; Cupissol, D; Eymard, JC; Lortholary, A; Mita, M; Pivot, X; Savary, J; Thyss, A	1
Esumi, K; Furukawa, H; Imamura, H; Inoue, Y; Ishida, H; Katoh, H; Kitani, K; Masuda, N; Masutani, S; Onishi, H; Shimizu, J; Tatsuta, M; Tomotsu, K; Tsuda, K; Usui, T	1
Egawa, C; Inaji, H; Koyama, H; Miyoshi, Y; Motomura, K; Noguchi, S; Taguchi, T; Takamura, Y; Tamaki, Y	1
Dallimore, NS; Fiander, AN; Khan, Z; Misra, G	1
Dörken, B; Krenn, V; Kretzschmar, A; Reichardt, P; Thuss-Patience, PC	1
Köhn, FM; Meineke, V; Pickl, U; Ring, J; Vogt, HJ	1
Amdur, RJ; Hinerman, RW; Mendenhall, WM; Monroe, AT; Morris, CG	1
Iwahashi, M; Nakamori, M; Nakamura, M; Yamaue, H	1
Kawaguchi, Y; Saji, S; Sugiyama, Y	1
Koga, H; Kuroiwa, K; Naito, S; Osada, Y; Tsuneyoshi, M; Yamaguchi, A	1
Hozumi, Y; Ito, Y; Iwata, H; Kobayashi, T; Morita, S; Ohno, S; Sakamoto, J; Toi, M	1
Akaza, H; Hinotsu, S; Kotake, T; Kuroda, M; Niijima, T	1
Chan, CK; Chan, LW; Chan, SF; Chan, SY; Cheng, CW; Cheung, HY; Lai, FM; Li, ML; Ng, CF; Wong, WS	1
Kim, R; Osaki, A; Tanabe, K; Toge, T	1
Buda, A; Colombo, N; Conte, PF; Floriani, I; Fossati, R; Mangioni, C; Ravaioli, A; Rossi, R; Torri, V	1
Nishiura, K; Obata, H; Okugawa, T; Tabata, T; Tanaka, K; Toyoda, N; Yanoh, K	1
Camaggi, CM; Cavallo, G; D'Angelo, R; Facchini, G; Fiore, F; Formato, R; Iaccarino, V; Iaffaioli, RV; Mantovani, G; Memoli, B; Petrella, G; Ricci, S; Rosato, G; Santangelo, M; Strocchi, E; Tortoriello, A	1
Akao, T; Habuchi, T; Kato, T; Li, Z; Mitsumori, K; Ohyama, C; Sato, K; Tsuchiya, N	1
Birtle, AJ; Harland, SJ; Newby, JC	1
Enomoto, T; Fujita, M; Murata, Y; Nakashima, R	1
Chen, Y; Gan, YH; Ge, NL; Ren, ZG; Wang, YH; Xia, JL; Yang, BW; Yie, SL; Zhang, BH	1
Biron, P; Bui, B; Caty, A; Culine, S; Curé, H; De Revel, T; Delva, R; Droz, JP; Duclos, B; Fizazi, K; Gligorov, J; Gomez, F; Gravis, G; Guillemaut, S; Lotz, JP; Peny, J; Provent, S; Ségura, C; Théodore, C; Viens, P	1
Bouvet, N; Ellershaw, C; Flamant, F; Habrand, JL; Marsden, HB; Martelli, H; Oberlin, O; Rey, A; Sanchez de Toledo, J; Spicer, RD; Spooner, D; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A	1
Aamdal, S; Aasebø, U; Bremnes, RM; Kaasa, S; Sundstrøm, S	1
Bercez, C; Bonneterre, J; Bonneterre, ME; Dervaux, B; Lenne, X	1
Bonde, CT; Kirkegaard, P; Mogensen, AM; Nielsen, K; Rasmussen, A	1
Abelairas Gómez, JM; Calvo, JM; Olivier Pascual, N	1
Oberlin, O; Orbach, D; Quintana, E; Rey, A; Sanchez de Toledo, J; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A	1
Bang, SM; Cho, EK; Im, SA; Lee, JH; Lee, SN; Lee, WK; Park, DK; Park, SH; Park, YH; Shin, DB	1
Chen, BJ; Lin, GB; Rong, RM; Wu, ZB; Wu, ZM	1
Hale, K; Lamm, DL; McGee, WR	1
Ahmad, T; Gibbens, I; Gore, M; Habeshaw, T; Hubner, R; Kaye, S; Keyzor, C; Rothermundt, C	1
Franzaring, L; Lehmann, J; Stöckle, M; Thüroff, J; Wellek, S	1
Chen, L; Jiang, WZ; Lu, YF; Pan, CE; Wu, WJ; Zeng, J	1
Imazu, T; Ito, S; Sugao, H; Yokomizo, S	1
Baltas, D; Filipowicz, I; Hoffmann, G; Kolotas, C; Kontova, M; Kuner, RP; Kurek, R; Martin, T; Pollow, B; Roddiger, SJ; Rogge, B; Zamboglou, N	1
Oosterlinck, W	1
Chen, D; Cheng, HY; Jia, YC; Xu, AM; Xu, W; Yang, YF	1
Bonacina, P; Butti, A; Cappoli, S; Esposito, N; Invernizzi, S; Librizzi, A; Locatelli, G; Trinchieri, A	1
André, T; Bennamoun, M; Carola, E; Flesch, M; Gamelin, E; Louvet, C; Nguyen, S; Rebischung, C; Van Ongeval, J; Ychou, M	1
Chen, CM; Cheng, SH; Clarke, JL; Horng, CF; Huang, AT; Jian, JJ; Liu, MC; Prosnitz, LR; Tsai, SY; Tsou, MH; West, M	1
Bertheault-Cvitkovic, F; Castèra, D; Combe, M; de la Lande, B; Demange, L; Garbay, JR; Graïc, Y; Krzisch, C; Leduc, B; Lucas, V; Mouret-Fourme, E; Nguyen, TD; Noguès, C; Rouëssé, J; Serin, D; Villet, R	1
Alberti, S; Angelucci, D; Cianchetti, E; Ficorella, C; Iacobelli, S; Lattanzio, R; Marchetti, P; Natoli, C; Piantelli, M; Ricevuto, E; Tinari, N	1
Chen, B; Ding, Q; Liu, B; Wang, Z; Yu, J; Zhang, P; Zhang, Y	1
Botti, G; Chiodini, P; D'Aiuto, G; De Maio, E; de Matteis, A; Di Maio, M; Gallo, C; Gravina, A; Labonia, V; Landi, G; Morabito, A; Normanno, N; Nuzzo, F; Pacilio, C; Perrone, F; Rossi, E	1
Ardavanis, A; Arnogiannaki, N; Chrysochoou, M; Ioannidis, G; Karamouzis, M; Missitzis, I; Orphanos, G; Pissakas, G; Rigatos, G; Scorilas, A; Sotiropoulou, A; Tryfonopoulos, D	1
Aoe, K; Hiraki, A; Maeda, T; Matsuda, E; Murakami, T; Uemori, Y; Ueoka, H	1
Friedrich, MG	1
Galimberti, V; Gandini, S; Gentilini, O; Goldhirsch, A; Intra, M; Luini, A; Peruzzotti, G; Veronesi, P; Veronesi, U; Winnikow, E	1
Bedano, PM; Brames, MJ; Einhorn, LH; Juliar, BE; Williams, SD	1
Mohagheghi, MA; Montazeri, A; Sadighi, S; Sadighi, Z	1
Al Harbi, T; Al-Faris, N; Doyle, J; Gassas, A; Goia, C; Pappo, A	1
Doglioni, C; Dognini, GP; Ferreri, AJ; Patriarca, C; Ponzoni, M; Verona, C	1
Castiglione-Gertsch, M; Coates, AS; Colleoni, M; Gelber, RD; Gelber, S; Goldhirsch, A; Pagani, O; Price, KN; Simoncini, E	1
Dengler, R; Fröhlich, F; Kroll, T; Lobodasch, K; Pachmann, K; Pachmann, U; Rengsberger, M; Schubert, R	1
Brewster, AE; Clark, GW; Crosby, TD; Escofet, X; Harvard, TJ; Lewis, WG; Morgan, MA; Roberts, SA	1
Hidaka, Y; Higashi, S; Ikushima, I; Ishii, A; Kanemaru, M; Ota, Y; Seguchi, K; Shima, M	1
Barduagni, M; Belli, F; D'Ottavio, AM; Gamucci, T; Magnolfi, E; Meliffi, L; Moscetti, L; Sperduti, I; Vaccaro, A	1
Bamias, A; Giannopoulos, A; Gourgoulis, G; Mountzios, G; Papaiakovou, EE; Rodolakis, A; Vlahos, G; Voulgaris, Z	1
Berrum-Svennung, I; Boman, H; Granfors, T; Holmäng, S; Jahnson, S	1
Aebi, S; Basser, R; Bernhard, J; Castiglione-Gertsch, M; Coates, AS; Colleoni, M; Forbes, JF; Gelber, RD; Goldhirsch, A; Green, MD; Hürny, C; Martinelli, G; Price, KN; Thürlimann, B; Yeo, W; Zahrieh, D; Zhang, JJ	1
Fujimoto, N; Hasui, Y; Iguchi, A; Kinukawa, N; Koga, H; Kuramoto, H; Naito, S; Yamaguchi, A	1
Cho, JY; Choi, SH; Lee, DK; Lee, KS; Lee, SI; Lee, SJ; Lim, JY; Paik, YH; Park, HJ; Yoon, DS	1
Arima, N; Iwase, H; Kai, K; Miyayama, H; Nishimura, R; Yamamoto, Y	1
Hayashi, K; Kitamura, M; Kosaki, G; Takahashi, I; Tominaga, T	1
Wils, JA	1
Mukaiyama, T; Ogawa, M	1
Athanasiades, A; Bafaloukos, D; Bamia, C; Fountzilas, G; Giannakakis, T; Kalogera-Fountzila, A; Kosmidis, P; Pavlidis, N; Skarlos, D	1
Hashine, K; Kasahara, K; Sumiyoshi, Y	1
Arai, Y; Kanba, T; Shichiri, Y; Yoshida, S	1
Lorvidhaya, V	1
Botti, C; Cavaliere, R; Cognetti, F; Lopez, M; Scinto, AF; Vici, P	1
Gertenbach, U; Hohenfellner, R; Huber, C; Meyenburg, W; Stöckle, M; Thüroff, JW; Voges, G; Wellek, S	1
Bianco, A; Cavaniglia, G; Frattina, A; Lunghi, F; Migliorini, V; Paccagnella, A; Pappagallo, GL; Segati, R; Sileni, VC; Zorat, P	1
Hiroshige, K; Ikeda, T; Korenaga, D; Nishizaki, T; Sugimachi, K; Takenaka, K; Yoshida, K	1
Asaishi, K; Hirata, K; Masuoka, H; Narimatsu, E; Okazaki, A; Okazaki, M; Okazaki, Y; Toda, K; Yamada, T	1
Brunetti, I; Conte, PF; Dargenio, F; Fanucchi, A; Gadducci, A; Giannessi, PG; Muttini, MP	1
Abe, R; Hatakeyama, Y; Hoshino, M; Igarashi, W; Koyama, Y; Ohtake, T; Ono, T; Sato, N	1
Higashida, T; Koishi, Y; Koyama, H; Masuyama, M; Miyata, K; Mugitani, T; Takeuchi, K; Tanaka, H; Taniguchi, H; Yamaguchi, T	1
Hasegawa, Y; Miyake, K; Murase, T; Obata, K; Ohshima, S; Okamura, K; Ono, Y; Sakata, T; Shimoji, T	1
Koyanagi, T; Maru, A; Nagamori, S; Nonomura, K; Seki, T; Shinohara, N; Takakura, F; Tanaka, M; Togashi, M	1
Fukushima, S; Hiramatsu, T; Hirao, Y; Momose, H; Ohashi, Y; Okajima, E; Ozono, S; Yoshida, K	1
Arakawa, S; Eto, H; Hamami, G; Kamidono, S; Nakamura, I; Obe, S; Ogawa, T; Oka, Y; Ueno, K; Yoshimura, K	1
Abe, B; Hanamoto, N; Higasibori, Y; Inoue, A; Ishida, G; Miyagawa, I; Nakahara, T; Sumi, F; Watanabe, N	1
Goya, N; Kihara, T; Nakazawa, H; Okumura, T; Onizuka, S; Ryoji, O; Sonoda, T; Tanabe, K; Toma, H; Tomoe, H	1
Fukushima, S; Furuhata, A; Hosaka, M; Ishizuka, E; Kondo, I; Kubota, Y; Miura, T; Moriyama, M; Noguchi, S; Shuin, T	1
Hirano, A; Ohkawa, T; Shinka, T; Uekado, Y	1
Fehske, W; Fischer, HP; Hartlapp, JH; Reichel, C	1
Berger, C; Body, G; Bougnoux, P; Calais, G; Chapet, S; Descamps, P; Lansac, J; Le Floch, O; Reynaud-Bougnoux, A	1
Brancaccio, L; Comella, G; Curcio, C; D'Aprile, M; Ferrante, G; Gentile, M; Gridelli, C; Palmeri, S; Rossi, A; Veltri, E	1
Burghouts, JT; Conroy, T; de Graeff, A; Fickers, MM; Lalisang, FM; Paillot, B; Wagener, DJ; Wils, J	1
Basar, M; Cetin, S; Erol, A; Ozgür, S	1
Corselli, G; Gervasi, F; Lio, D; Pavone-Macaluso, M; Piazza, B; Salerno, S; Serretta, V	1
Clavel, M; Cognetti, F; de Mulder, PH; Kirkpatrick, A; Rodenhuis, S; Snow, GB; Vermorken, JB; Verweij, J	1
Hammond, B; Kurth, KH; Oosterlinck, W; Schröder, F; Sylvester, R	1
Chionis, HS; Dauaher, HH; Melekos, MD; Paranychianakis, GS	1
Imamura, H; Kobayashi, K; Miyazaki, M; Nakayama, T; Shin, E; Takatsuka, Y; Tamaki, Y; Taniguchi, K; Touno, K; Yagyu, T	1
Ciavattini, A; Cignitti, M; Fabris, N; Garzetti, GG; Romanini, C	1
Lauchart, W; Pirschel, J	1
Bultinck, J; Hammond, B; Kurth, KH; Oosterlinck, W; Schröder, F; Sylvester, R	1
Bonneterre, J; Mercier, M	1
Lukkarinen, O; Raitanen, MP	1
Barbanti, G; De Capua, B; De Lauretis, A; Francini, G; Frediani, B; Manganelli, A; Mondillo, S; Petrioli, R; Salvestrini, F	1
Pavone, C; Pavone-Macaluso, M; Piazza, B; Piazza, S; Serretta, V	1
Malvestiti, GM; Pozzi, E; Roggia, A	1
Bondovalli, C; Dall'Oglio, B; Luciano, M; Parma, A; Pegoraro, C; Schiavon, L	1
Altug, U; Erol, D; Uygur, MC; Yaman, I	1
Igawa, M; Ishibe, T; Kadena, H; Kawanishi, M; Shiina, H; Shirakawa, H; Urakami, S; Usui, T	1
Klonaris, C; Kosmas, C; Kosmidis, P; Lisaios, B; Mandrekois, D; Mylonakis, N; Sakelaropoulos, N; Soumilas, A; Tentas, K; Tsavaris, NB; Tsetis, A	1
Beysel, M; Erdoğan, K; Erol, A; Sengör, F; Tuzluoğlu, D	1
Hamada, E; Ikawa, M; Matsumoto, Y; Miura, T; Murata, M; Nakasato, S; Takaki, S; Terakado, H; Watanabe, Y	1
Fujita, Y; Inoue, K; Inoue, Y; Kasahara, K; Morioka, M; Shuin, T; Yamashita, M	1
Ino, M; Noda, H; Takahashi, S; Takeuchi, S; Tanaka, T; Tateoka, H; Yokoyama, M	1
Flannigan, GM; Hamilton Stewart, PA; Lowe, J; Nargund, VH	1
Dubowik, R; Gabryś, K; Urbaniak-Kujda, D	1
Adamo, V; Altavilla, G; Caristi, N; Chiofalo, G; Maisano, R; Pergolizzi, S; Scimone, A; Settineri, N	1
Barbalias, G; Chionis, H; Dandinis, K; Dauaher, H; Fokaefs, E; Melekos, MD; Zarakovitis, I	1
Hayashi, T; Kohno, H; Nagasue, N; Ono, T; Uchida, M; Yamanoi, A; Yukaya, H	1
Kato, Y; Maeyama, S; Mamada, Y; Mizuno, H; Okabe, K; Sakuyama, K; Sato, A; Shinagawa, T; Suemori, S; Suga, M; Suzuki, H; Suzuki, M; Tominaga, T; Yamamoto, T; Yamanouchi, E	1
Ali-el-Dein, B; Ashamallah, A; el-Baz, M; Nabeeh, A; Shamaa, S	1
Ali-el-Dein, B; Aly, AN; Ashamallah, A; el-Baz, M; Shamaa, S	1
Athanassiou, A; Dimitriades, M; Kostopoulou, M; Mylonakis, A; Papadopoulou, M; Pectasides, D; Triantafillis, D; Varthalitis, J	1
Cortés-Funes, H; García-Conde, J; Hornedo, J; Lluch, A; López, J; Sola, C; Solano, C	1
Doi, T; Ehara, H; Fujihiro, S; Fujimoto, Y; Hasegawa, Y; Hayashi, H; Horie, M; Isogai, K; Itoh, F; Kanematsu, M; Kawada, Y; Kobayashi, S; Kuriyama, M; Maeda, S; Matsuda, S; Sakai, S; Takahashi, Y; Takeda, A; Takeuchi, T; Tei, KH; Yamada, S	1
Caforio, M; Caleffi, G; Cantore, M; Cavazzini, G; Fiorentini, G; Mambrini, A; Molani, L; Morandi, C; Smerieri, F; Zamagni, D	1
Gabriele, A; Gorga, G; Landoni, F; Lissoni, A; Mangioni, C; Sessa, C; Tumolo, S	1
Rosen, M	1
Tsukuda, M	1
Shin, E; Takatsuka, Y	1
Armillotta, N; Bartolozzi, C; Cicorelli, A; Cioni, D; Di Giulio, M; Donati, F; Lencioni, R; Moretti, M; Paolicchi, A; Pinto, F	1
Iwai, S; Kono, S; Takano, S	1
Bacci, G; Bertoni, F; Briccoli, A; Campanacci, M; Cesari, M; Fabbri, N; Ferrari, S; Forni, C; Gasbarrini, A; Mercuri, M	1
Fukatsu, T; Itoh, H; Kinukawa, T; Kobayashi, H; Kobayashi, M; Matsuura, O; Ohshima, S; Okamura, K; Otani, T; Tsumura, Y	1
Birch, BR; Cooper, AJ; Foley, SJ; Jennings, AM; Solomon, LZ	1
An, M; Hamada, E; Idezuki, Y; Ikawa, M; Kishi, T; Kobayashi, M; Matsumoto, Y; Miura, T; Murata, M; Nakasato, S; Takaki, S; Terakado, H; Watanabe, Y	1
Fukunaga, M; Hasegawa, S; Hirao, T; Imamoto, H; Kan, K; Kondo, M; Maruyama, H; Ohzato, H; Takatsuka, Y; Tono, T; Yamazaki, K; Yongman, K	1
Bengtsson, NO; Bergh, JC; Fornander, TG; Hatschek, T; Jansson, TE; Karlsson, YA; Malmström, PO; Sjöberg, SM; Söderberg, M	1
Borden, EC; Green, M; Haller, DG; Marsh, JC; Rosenthal, MA; Wiernik, P	1
Callegaro, D; Fantoni, U; Favaretto, A; Festi, G; Loy, M; Paccagnella, A; Rea, F; Sartori, F	1
Idezuki, Y; Ishizuka, N; Kobayashi, M; Murata, N; Suwata, J; Takada, S	1
Kobayashi, M; Kobayashi, Y; Morita, T; Sugaya, Y; Tokue, A; Yuzawa, M	1
Arnoud, L; Belichard, C; Coudert, B; Darut-Jouve, A; Guerrin, J; Jolimoy, G	1
Helle, M; Kaasinen, E; Liukkonen, T; Lukkarinen, O; Raitanen, M; Rajala, P; Rintala, E	1
Coptcoat, MJ; Gibson, D; Masters, JR; Parmar, MK; Popert, RJ; Thompson, PM	1
Bertero, G; Cosso, M; Neumaier, C; Palumbo, R; Pastorino, M; Raffo, P; Spadini, N; Toma, S; Valente, S; Villani, G	1
Alonso, S; Armand, JP; Chouaki, N; Cortès-Funes, H; Cvitkovic, E; Fandi, A; Hasbini, A; Lianes, P; Mahjoubi, R; Raymond, E; Taamma, A	1
Hatzl-Griesenhofer, M; Huber, H; Maschek, W; Pichler, R; Wahl, G; Wimmer, G	1
Arrufat Boix, JM; Cuñat Albert, E; Francisco Mingol, V; Gallego Gómez, J; Pérez Mestre, M	1
Billgren, AM; Fornander, T; Rutqvist, LE; Skoog, L; Tani, E; Wilking, N	1
Ohashi, Y; Yamaguchi, T	1
Armand, JP; Azli, N; Chouaki, N; Couteau, C; Cvitkovic, E; Fandi, A; Hasbini, A; Taamma, A; Wibault, P	1
Aitken, SE; Huan, SD; Segal, R; Stewart, DJ; Yau, JC	1
Akaza, H; Hinotsu, S; Kotake, T; Ohashi, Y	1
Bliss, JM; Coombes, G; Coombes, RC; Fontaine, C; Marty, M; Morvan, F; Olmos, T; Pérez-López, FR; Vassilopoulos, P; Wils, JA; Woods, E	1
Chauvergne, J; Fervers, B; Fondrinier, E; Guastalla, JP; Haie-Meder, C; Lhommé, C; Resbeut, M	1
Bisagni, G; Boni, C; Ceci, G; Cocconi, G; De Lisi, V; Di Blasio, B; Morandi, P; Passalacqua, R; Savoldi, L; Zadro, A	1
Bang, YJ; Ha, SW; Huh, DS; Kim, IH; Park, CI; Wu, HG	1
Bekradda, M; Bensmaïne, MA; Brain, E; Cvitkovic, E; Di Palma, M; Garrino, C; Goupil, A; Misset, JL; Soulié, P	1
Brunetti, I; Bruzzone, M; Carnino, F; Chiara, S; Conte, PF; Gadducci, A; Romanini, A; Tanganelli, L	1
Celik, S; Evrensel, T; Orhan, B; Samli, B; Tasdelen, I	1
Chang, FY; Chau, GY; Chiang, JH; Huang, YH; Huo, TI; King, KL; Lee, SD; Lui, WY; Tsay, SH; Wu, JC	1
Aki, FT; Aygün, C; Bilen, CY; Ekici, S; Kendi, S; Ozen, H	1
Aoki, Y; Arai, Y; Maeda, H; Maekawa, S; Ogura, K; Ohkubo, K; Okada, T; Suzuki, H	1
Cervenakov, I; Chovan, D; Mala, M; Mardiak, J; Slavov, D; Szoldova, K	1
Fukushima, Y; Fuzita, J; Hata, S; Hayashida, H; Ikeda, K; Ishida, T; Kitada, M; Nakamura, T; Niinobu, T; Shibata, T; Shimano, T; Suzuki, R; Takahashi, Y; Takami, M; Tukahara, Y	1
Cosio, S; Cristofani, R; Fanucchi, A; Gadducci, A; Iacconi, P; Riccardo Genazzani, A	1
Budach, W	1
Foekens, JA; Klijn, JG; Look, MP; Martin, PM; Romain, S	1
Markman, M	1
Feyerabend, T; Jäger, B; Mahlmann, B; Richter, E; Vesely, H; Wiedemann, GJ	1
Kohno, H; Nagasue, N; Nazmy El Assal, O; Ono, T; Yamanoi, A	1
Airoldi, M; Bumma, C; De Crescenzo, A; Gabriele, AM; Marchionatti, S; Pedani, F; Rosti, G; Succo, G	1
Abrahamova, J; Kocak, I; Kroslakova, D; Kubala, E; Machova, D; Malec, V; Pavlikova, E; Pavlikova, I; Prausova, J; Simova, E; Sirakova, I; Tuma, P; Van Praagh, I; Wagnerova, M	1
Dewar, JA; Ferguson, MJ	1
Duchateau, L; Julien, JP; Tubiana-Hulin, M; van de Velde, CJ; van der Hage, JA; Vandervelden, C	1
Biesma, B; Giaccone, G; Huisman, C; Postmus, PE; Schramel, FM; Smit, EF	1
Chung, NN; Hong, RL; Hsu, MM; Ko, JY; Lou, PJ; Lui, LT; Sheen, TS; Ting, LL; Wang, CC	1
Bono, AV; Brausi, M; de Balincourt, C; Hall, R; Mack, D; Oosterlinck, W; Sylvester, R	1
Dunst, J; Haensgen, G	1
Akaza, H; Hinotsu, S; Isaka, S; Kagawa, S; Koiso, K; Kotake, T; Machida, T; Matsumura, Y; Niijima, T; Obata, K; Ohashi, Y; Ohe, H; Shimazaki, J; Tashiro, K	1
Bakirtaş, H; Ersoy, H; Imamoğlu, MA; Sertçelik, AN; Yiğitbaşi, O	1
Amicucci, G; Deraco, M; Fiorentini, G; Guadagni, S; Miotto, D; Palumbo, G; Pilati, PL; Rossi, CR; Russo, F; Santinami, M; Valenti, M	1
Avilés, A; Díaz-Maqueo, JC; García, EL; Neri, N; Talavera, A	1
Inaji, H; Kobayashi, H; Motomura, K; Noguchi, S; Taguchi, T; Takamura, Y	1
Chen, B; Ding, Q; Jiang, H; Liu, B; Wang, J; Wang, Z; Zhang, Y	1
Jänicke, F	1
Dueñas, R; Fernández, M; Jaén, A; Lozano, A; Martínez, E; Medina, B; Mohedano, N; Porras, I; Sánchez-Rovira, P	1
Anderson, N; Golchin, K; Primrose, WJ; Raut, V	1
Mauceri, G; Mazzone, G; Morgia, G; Motta, M	1
Collard, P; Francis, C; Rodenstein, DO; Weynants, P	1
Cannito, F; Castellan, L; Chiesura-Corona, M; el Khatib, AB; Feltrin, GP; Miotto, D; Roman, E; Sandri, P; Savastano, S; Torraco, A	1
Newling, DW	1
Debruyne, FM; Kurth, KH; Oosterlinck, W; van der Meijden, AP	1
Bonichon, F; Chauvergne, J; Dilhuydy, JM; Durand, M; Mauriac, L	1
Awane, Y; Maeshiro, T; Matsumine, T; Miyamoto, S; Umekita, N; Yamada, F	1
Doki, Y; Ohmachi, Y; Okamura, Y; Takatsuka, Y	1
Ishii, S; Nohga, K; Yokoyama, I	1
Cunningham, D; Husband, JE; MacVicar, D; Menzies-Gow, N; Taylor, R	1
Brandão, T; da Silva, FC; Ferrito, F; Santos, A	1
Castagnetti, G; Ferrari, G; Ferrari, P; Grassi, D; Pollastri, CA; Tavoni, F	1
Kefford, R; Raghavan, D; Rosenthal, M; Stuart-Harris, R	1
Barbalias, G; Dauaher, H; Fokaefs, E; Melekos, MD	1
Corselli, G; Pavone, C; Pavone-Macaluso, M; Pizzuto Antinoro, SA; Serretta, V	1
Bogdanowicz, JF; Carpentier, PJ; Kurth, K; ten Kate, F; Van Reyswoud, I; Vijgh, WJ	1
Avril, A; Dilhuydy, JM; Durand, M; Mauriac, L	1
Dawson, K; Dick, R; Kelleher, SM; Novell, JR; Parbhoo, SP	1
Chang, AY; Chen, KY; Jame, JM; Law, CK; Li, WY; Lin, CZ; Zen, HG	1
Hellström, P; Kontturi, M; Lukkarinen, O; Nurmi, M; Ottelin, J; Paul, C; Puntala, P; Tammela, T; Tidefeldt, U	1
Ali, NM; Eissa, S; Elattar, I; Elsebai, I; Gad el Mawla, N; Habboubi, N; Hamza, MR; Khaled, H; Magrath, I; Mansour, MA	1
Cumming, JA; Garvie, WH; Hargreave, TB; Kirk, D; Newling, DW; Robinson, MR; Smith, PH; Whelan, P	1
Halligan, AW; McGuinness, EP	1
Bokemeyer, C; Burk, K; Dölken, G; Harstrick, A; Poliwoda, H; Schmoll, HJ; Schöber, C; Stahl, M; Wilke, H; Wömpner, CK	1
Damianov, Kh; Patrashkov, T; Petkov, Ts; Petrov, P; Tonchev, T	1
Airoldi, M; Brando, V; Gabriele, P; Giordano, C; Pedani, F	1
Buxton, J; Chetiyawardana, A; Crawford, M; Lawton, F; Mould, J; O'Brien, M; Patterson, M; Redman, C; Stuart, N; Sykes, V	1
Collins, JP; Green, MD; Russell, IS; Smith, JA	1
Kumanov, Kh; Ormanov, I; Tsvetkov, M	1
Burk, K; Kurth, KH; Newling, D	1
Choy, DT; Ma, HK; Ngan, HY; Sham, JS; Wong, LC	1
Kawahara, T; Nakayama, H; Takatsuka, Y	1
Arnold, H; Flechtner, H; Fritsch, H; Fritz, M; Fritze, D; Heim, ME; Henss, H; Herrmann, R; Queisser, W; Trux, FA	1
Diedrich, K; Heuer, J; Krebs, D; Oberheuser, F; Schulz, BO; Werner, A	1
Sakata, Y; Yoshida, Y	1
Izuo, M; Nakajima, M; Ogawa, M; Taguchi, T; Terasawa, T; Yoshida, M	1

Reviews

22 review(s) available for epirubicin and Local Neoplasm Recurrence

Article	Year
Comparison Between Intravesical Chemotherapy Epirubicin and Mitomycin-C after TURB vs TURB Alone With Recurrence Rate of Non-Muscle Invasive Bladder Cancer: Meta-Analysis. Medical archives (Sarajevo, Bosnia and Herzegovina), 2022, Volume: 76, Issue:3 Topics: Administration, Intravesical; Carcinoma, Transitional Cell; Epirubicin; Female; Humans; Male; Mitomycin; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic; Urinary Bladder Neoplasms	2022
Selection of Patients With Localized Extremity Soft Tissue Sarcoma for Treatment With Perioperative Chemotherapy. Current treatment options in oncology, 2018, 10-25, Volume: 19, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxorubicin; Epirubicin; Humans; Ifosfamide; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sarcoma; Soft Tissue Neoplasms	2018
Long-term versus short-term introvesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review and meta-analysis of the published results of randomized clinical trials. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2014, Volume: 34, Issue:5 Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Drug Therapy; Epirubicin; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms	2014
Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma European urology, 2016, Volume: 69, Issue:2 Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Disease Progression; Doxorubicin; Epirubicin; Humans; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate; Thiotepa; Time Factors; Urinary Bladder Neoplasms	2016
Evaluating the efficacy and safety of intravesical chemotherapies for non-muscle invasive bladder cancer: a network meta-analysis. Oncotarget, 2016, Dec-13, Volume: 7, Issue:50 Topics: Administration, Intravesical; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; BCG Vaccine; Deoxycytidine; Disease Progression; Epirubicin; Female; Gemcitabine; Humans; Isoniazid; Male; Middle Aged; Mitomycin; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Odds Ratio; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms	2016
Ciprofloxacin criteria in antimicrobial prophylaxis and bladder cancer recurrence. Medical science monitor : international medical journal of experimental and clinical research, 2010, Volume: 16, Issue:10 Topics: Anti-Infective Agents; Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Line, Tumor; Ciprofloxacin; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Epirubicin; Humans; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	2010
Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy. Breast cancer (Tokyo, Japan), 2011, Volume: 18, Issue:3 Topics: Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Mastectomy, Segmental; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Platinum; Receptors, Estrogen; Taxoids	2011
Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer. The Cochrane database of systematic reviews, 2011, May-11, Issue:5 Topics: Adjuvants, Immunologic; Administration, Intravesical; Antibiotics, Antineoplastic; BCG Vaccine; Epirubicin; Humans; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic; Urinary Bladder Neoplasms	2011
[The role of neoadjuvant chemotherapy for breast cancer treatment]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Epirubicin; Female; Humans; Mastectomy, Segmental; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Preoperative Care; Prognosis	2002
Breast-conserving treatment after neoadjuvant chemotherapy in large breast cancer. Breast cancer (Tokyo, Japan), 2002, Volume: 9, Issue:1 Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Epirubicin; Female; Humans; Mastectomy, Segmental; Neoadjuvant Therapy; Neoplasm Recurrence, Local	2002
[Activity of paclitaxel, epirubicin and carboplatin in patients with advanced or recurrent endometrial cancer]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Endometrial Neoplasms; Epirubicin; Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Postoperative Care; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Treatment Outcome	2004
[Orbital rhabdomyosarcoma: difficulties with European treatment protocol]. Archivos de la Sociedad Espanola de Oftalmologia, 2005, Volume: 80, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Clinical Protocols; Combined Modality Therapy; Cranial Irradiation; Dactinomycin; Disease-Free Survival; Epirubicin; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Life Tables; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Orbital Neoplasms; Radiation Injuries; Radiotherapy, Adjuvant; Reoperation; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vincristine	2005
Bladder cancer: current optimal intravesical treatment. Urologic nursing, 2005, Volume: 25, Issue:5 Topics: Adjuvants, Immunologic; Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Cystectomy; Doxorubicin; Drug Administration Schedule; Epirubicin; Humans; Interferon-alpha; Mitomycin; Neoplasm Recurrence, Local; Nurse's Role; Patient Selection; Risk Factors; Salvage Therapy; Survival Rate; Thiotepa; Treatment Failure; United States; Urinary Bladder Neoplasms	2005
[Treatment strategy to obtain cure for recurrent advanced breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21 Suppl 2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Carmustine; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm Recurrence, Local; Thiotepa	1994
[Treatment for recurrent head and neck carcinomas]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Combined Modality Therapy; Epirubicin; Fluorouracil; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy Dosage	1998
[Treatment strategy for recurrent breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Floxuridine; Fluorouracil; Gonadotropin-Releasing Hormone; Humans; Infusions, Intravenous; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Palliative Care; Survival Rate; Tamoxifen	1998
Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: a combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function. Cancer, 1999, Nov-01, Volume: 86, Issue:9 Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Transitional Cell; Doxorubicin; Epirubicin; Female; Humans; Male; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Risk; Time Factors; Urinary Bladder Neoplasms	1999
[Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR]. Bulletin du cancer, 1999, Volume: 86, Issue:10 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Epirubicin; Female; Fluorouracil; Humans; Hydroxyurea; Lymphatic Metastasis; Multicenter Studies as Topic; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Practice Guidelines as Topic; Prognosis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms	1999
Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials. Cancer, 2001, Jun-15, Volume: 91, Issue:12 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Drug Tolerance; Epirubicin; Female; Fluorouracil; Hepatectomy; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Multivariate Analysis; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Tegafur; Treatment Outcome	2001
Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2001, Volume: 177, Issue:12 Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Middle Aged; Mitomycin; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Recurrence, Local; Postoperative Care; Radiation-Sensitizing Agents; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Uterine Cervical Neoplasms	2001
Selection criteria for epirubicin-based adjuvant chemotherapy in node-negative breast cancer. Clinical breast cancer, 2000, Volume: 1 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Enzyme-Linked Immunosorbent Assay; Epirubicin; Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Plasminogen Activator Inhibitor 1; Prognosis; Urokinase-Type Plasminogen Activator	2000
Neoadjuvant gemcitabine therapy for breast cancer. Clinical breast cancer, 2002, Volume: 3 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials, Phase II as Topic; Deoxycytidine; Doxorubicin; Epirubicin; Female; Gemcitabine; Humans; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Treatment Outcome	2002

Trials

161 trial(s) available for epirubicin and Local Neoplasm Recurrence

Article	Year
Single Versus Maintenance Intravesical Chemotherapy for the Prevention of Bladder Recurrence after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Randomized Clinical Trial. Clinical genitourinary cancer, 2019, Volume: 17, Issue:6 Topics: Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Drug Administration Schedule; Epirubicin; Female; Humans; Maintenance Chemotherapy; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Nephroureterectomy; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms	2019
Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy. European journal of cancer (Oxford, England : 1990), 2020, Volume: 127 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; BRCA1 Protein; BRCA2 Protein; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphocytes, Tumor-Infiltrating; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Survival Rate; Thiotepa; Triple Negative Breast Neoplasms	2020
A Randomized Parallel Controlled Phase II Trial of Recombinant Human Endostatin Added to Neoadjuvant Chemotherapy for Stage III Breast Cancer. Clinical breast cancer, 2020, Volume: 20, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Endostatins; Epirubicin; Female; Follow-Up Studies; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy, Adjuvant; Recombinant Proteins	2020
Factors predictive of locoregional recurrence following neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancer: An analysis of the EORTC 10994/BIG 1-00 study. European journal of cancer (Oxford, England : 1990), 2017, Volume: 79 Topics: Adult; Age of Onset; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Taxoids; Trastuzumab; Treatment Outcome	2017
BRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trial. Breast cancer research and treatment, 2017, Volume: 166, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Capecitabine; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Humans; Middle Aged; Myeloablative Agonists; Neoplasm Recurrence, Local; Paclitaxel; Triple Negative Breast Neoplasms	2017
Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Nov-10, Volume: 35, Issue:32 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Epirubicin; Esophagogastric Junction; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Risk Factors; Stomach Neoplasms; Survival Rate; Treatment Outcome; United States	2017
The value of immediate postoperative intravesical epirubicin instillation as an adjunct to standard adjuvant treatment in intermediate and high-risk non-muscle-invasive bladder cancer: A preliminary results of randomized controlled trial. Urologic oncology, 2019, Volume: 37, Issue:3 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Cystectomy; Cystoscopy; Disease Progression; Epirubicin; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Progression-Free Survival; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms; Young Adult	2019
Evaluation of the effects of intra-arterial chemotherapy combined with intravesical chemotherapy against intravesical chemotherapy alone after transurethral resection of bladder tumor in T1-staged Grade 3 bladder cancer. Journal of cancer research and clinical oncology, 2019, Volume: 145, Issue:2 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Female; Follow-Up Studies; Humans; Injections, Intra-Arterial; Male; Middle Aged; Muscle Neoplasms; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate; Urinary Bladder Neoplasms	2019
Comparing intra-arterial chemotherapy combined with intravesical chemotherapy versus intravesical chemotherapy alone: a randomised prospective pilot study for T1G3 bladder transitional cell carcinoma after bladder-preserving surgery. Cardiovascular and interventional radiology, 2013, Volume: 36, Issue:6 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Disease Progression; Drug Therapy, Combination; Epirubicin; Female; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm Recurrence, Local; Organ Sparing Treatments; Pilot Projects; Prospective Studies; Survival Analysis; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms	2013
Unfavorable pathological complete response rate of neoadjuvant chemotherapy epirubicin plus taxanes for locally advanced triple-negative breast cancer. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2013, Volume: 33, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Disease-Free Survival; Docetaxel; Epirubicin; Female; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm, Residual; Paclitaxel; Taxoids; Treatment Failure; Treatment Outcome; Triple Negative Breast Neoplasms	2013
Adding preoperative radiotherapy plus cetuximab to perioperative chemotherapy for resectable esophageal adenocarcinoma: a single-center prospective phase II trial. The oncologist, 2014, Volume: 19, Issue:1 Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cetuximab; Chemoradiotherapy; Cisplatin; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Perioperative Care; Preoperative Care; Prospective Studies; Survivors	2014
Brachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency. Radiation oncology (London, England), 2014, Mar-01, Volume: 9 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma; Chemoradiotherapy, Adjuvant; Cisplatin; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; International Agencies; Male; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Nuclear Energy; Prognosis; Prospective Studies; Radiation Injuries; Radiotherapy Dosage; Survival Rate	2014
The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911. European urology, 2014, Volume: 66, Issue:4 Topics: Age Factors; Aged; Aged, 80 and over; BCG Vaccine; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cystectomy; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Proportional Hazards Models; Risk Assessment; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms	2014
Prognostic factors of survival in pathologic incomplete response patients with locally advanced breast cancer after neoadjuvant chemotherapy. Cell biochemistry and biophysics, 2015, Volume: 71, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; China; Disease-Free Survival; Epirubicin; Female; Humans; Incidence; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Prognosis; Risk Factors; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine	2015
Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy. Pediatric blood & cancer, 2015, Volume: 62, Issue:11 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Retrospective Studies; Rhabdomyosarcoma; Survival Rate; Vincristine	2015
Cardiac assessment of early breast cancer patients 18 years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy. European journal of cancer (Oxford, England : 1990), 2015, Volume: 51, Issue:17 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Echocardiography; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Heart Failure; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Prognosis; Proportional Hazards Models; Survival Rate; Ventricular Dysfunction, Left	2015
Feasibility of Preoperative Chemotherapy With or Without Radiation Therapy in Localized Soft Tissue Sarcomas of Limbs and Superficial Trunk in the Italian Sarcoma Group/Grupo Español de Investigación en Sarcomas Randomized Clinical Trial: Three Versus Fiv Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Nov-01, Volume: 33, Issue:31 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Extremities; Feasibility Studies; Female; Humans; Ifosfamide; Italy; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy; Regression Analysis; Sarcoma; Soft Tissue Neoplasms; Spain; Wound Healing; Young Adult	2015
Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial. Anticancer research, 2016, Volume: 36, Issue:9 Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Middle Aged; Mucin-1; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplastic Cells, Circulating; Prognosis; Taxoids	2016
Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial. JAMA, 2016, 11-08, Volume: 316, Issue:18 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Austria; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Germany; Humans; Middle Aged; Neoplasm Recurrence, Local; Quality of Life; Sweden; Taxoids	2016
Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy. Gynecologic oncology, 2008, Volume: 110, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Endometrial Neoplasms; Epirubicin; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy, Adjuvant; Risk Factors; Survival Rate	2008
A phase II study of weekly paclitaxel and epirubicin in recurrent or refractory squamous cell carcinoma of the head and neck. Japanese journal of clinical oncology, 2008, Volume: 38, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug-Related Side Effects and Adverse Reactions; Epirubicin; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Platinum Compounds; Survival Analysis	2008
Dose escalation study of epirubicin and docetaxel in patients with advanced or recurrent breast cancer. Chemotherapy, 2008, Volume: 54, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Taxoids	2008
Docetaxel and epirubicin salvage regimen in relapsed anthracycline-sensitive metastatic breast cancer patients after anthracycline-containing adjuvant therapy. Investigational new drugs, 2009, Volume: 27, Issue:1 Topics: Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Docetaxel; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Recurrence; Salvage Therapy; Survival Analysis; Taxoids	2009
[Safety of adjuvant dose-dense chemotherapy with paclitaxel and epirubicin for high-risk breast cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2008, Volume: 30, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Epirubicin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphatic Metastasis; Mastectomy; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Neutropenia; Paclitaxel; Survival Rate; Vomiting; Young Adult	2008
[Intravesical instillation with epirubicin as a prophylactic treatment for superficial bladder cancer--using two different schedules]. Hinyokika kiyo. Acta urologica Japonica, 2008, Volume: 54, Issue:11 Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Cystectomy; Drug Administration Schedule; Epirubicin; Female; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Prospective Studies; Risk Factors; Urinary Bladder Neoplasms	2008
Phase II study of epirubicin in combination with weekly docetaxel for patients with advanced NSCLC who have failed or relapsed after the frontline platinum-based chemotherapy. American journal of clinical oncology, 2009, Volume: 32, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Docetaxel; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Salvage Therapy; Survival Rate; Taxoids; Treatment Failure	2009
Bacillus Calmette-Guérin is superior to a combination of epirubicin and interferon-alpha2b in the intravesical treatment of patients with stage T1 urinary bladder cancer. A prospective, randomized, Nordic study. European urology, 2010, Volume: 57, Issue:1 Topics: Administration, Intravesical; Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma; Chemotherapy, Adjuvant; Cystectomy; Disease Progression; Disease-Free Survival; Epirubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Kaplan-Meier Estimate; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Prospective Studies; Recombinant Proteins; Risk Assessment; Risk Factors; Scandinavian and Nordic Countries; Time Factors; Treatment Outcome; Tumor Burden; Urinary Bladder Neoplasms	2010
Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Dec-01, Volume: 27, Issue:34 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Receptor, ErbB-2; Survival Rate; Taxoids; Trastuzumab; Vinblastine; Vinorelbine	2009
Two instillations of epirubicin as prophylaxis for recurrence after transurethral resection of Ta and T1 transitional cell bladder cancer: a prospective, randomized controlled study. World journal of urology, 2010, Volume: 28, Issue:4 Topics: Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Prospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Urologic Surgical Procedures	2010
A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer. BJU international, 2010, Volume: 106, Issue:2 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Combined Modality Therapy; Cystoscopy; Epidemiologic Methods; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Treatment Outcome; Urinary Bladder Neoplasms	2010
Intra-arterial chemotherapy is reliable in preventing high-risk superficial bladder cancer from recurrence and progression. Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:6 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Disease Progression; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	2009
Multicenter phase 2 study of combined gemcitabine and epirubicin as second-line treatment for patients with advanced ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2010, Volume: 20, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Infusions, Intravenous; Italy; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Remission Induction; Survival Analysis; Treatment Outcome	2010
Maintenance therapy with bacillus Calmette-Guérin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer. BJU international, 2011, Volume: 108, Issue:2 Topics: Adjuvants, Immunologic; Administration, Intravesical; Adult; Aged; Antineoplastic Agents; BCG Vaccine; Combined Modality Therapy; Cystectomy; Disease-Free Survival; Epidemiologic Methods; Epirubicin; Female; Humans; Male; Middle Aged; Mycobacterium bovis; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Treatment Outcome; Urinary Bladder Neoplasms; Young Adult	2011
[Gemcitabine based combination chemotherapy, a new salvage regimen for recurrent platinum resistant epithelial ovarian cancer]. Zhonghua fu chan ke za zhi, 2010, Volume: 45, Issue:11 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Resistance, Neoplasm; Epirubicin; Female; Gemcitabine; Humans; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Ovarian Neoplasms; Platinum Compounds; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome	2010
Health-related quality of life as prognostic factor for response, progression-free survival, and survival in women with metastatic breast cancer. Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Health Status; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prognosis; Prospective Studies; Quality of Life; Survival Rate; Young Adult	2012
A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study. Journal of experimental & clinical cancer research : CR, 2011, Apr-12, Volume: 30 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Polyethylene Glycols; Prospective Studies; Soft Tissue Neoplasms; Vinblastine; Vinorelbine; Viscera	2011
Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: improved prognosis in triple-negative tumors. Drugs in R&D, 2011, Volume: 11, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deoxycytidine; Docetaxel; Epirubicin; Female; Gemcitabine; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Analysis; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine; Young Adult	2011
Recurrence risk score based on the specific activity of CDK1 and CDK2 predicts response to neoadjuvant paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide in breast cancers. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; CDC2 Protein Kinase; Cyclin-Dependent Kinase 2; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Ki-67 Antigen; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Receptors, Steroid; Risk Factors; Treatment Outcome	2012
[Evaluation of the efficacy and safety of intravesical instillation with gemcitabine after first-line intravesical chemotherapy failure in the treatment of non-muscle-invasive bladder cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:5 Topics: Administration, Intravesical; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Mitomycin; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	2011
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial. Breast cancer research and treatment, 2012, Volume: 132, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Greece; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Proportional Hazards Models; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Young Adult	2012
Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial. Annals of surgical oncology, 2012, Volume: 19, Issue:7 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Prognosis; Survival Rate; Young Adult	2012
A prospective randomized controlled trial of preoperative whole-liver chemolipiodolization for hepatocellular carcinoma. Digestive diseases and sciences, 2012, Volume: 57, Issue:5 Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheterization; Chemotherapy, Adjuvant; Disease-Free Survival; Epirubicin; Ethiodized Oil; Female; Hepatectomy; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Outcome and Process Assessment, Health Care; Postoperative Complications; Preoperative Care; Treatment Outcome	2012
The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Oncology G Breast cancer research : BCR, 2012, Nov-12, Volume: 14, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemoradiotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; In Situ Hybridization, Fluorescence; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor B; Vascular Endothelial Growth Factor C; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factor Receptor-3; Vascular Endothelial Growth Factors; Young Adult	2012
Dynamic contrast-enhanced MR imaging in a phase Ⅱ study on neoadjuvant chemotherapy combining Rh-endostatin with docetaxel and epirubicin for locally advanced breast cancer. International journal of medical sciences, 2013, Volume: 10, Issue:2 Topics: Adolescent; Adult; Aged; Breast Neoplasms; Docetaxel; Endostatins; Epirubicin; Female; Humans; Magnetic Resonance Imaging; Microvessels; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Radiography; Taxoids	2013
Perioperative single dose instillation of epirubicin or interferon-alpha after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a prospective randomized multicenter study--FinnBladder III long-term results. The Journal of urology, 2002, Volume: 168, Issue:3 Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Combined Modality Therapy; Epirubicin; Female; Humans; Interferon-alpha; Male; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Prospective Studies; Urinary Bladder Neoplasms	2002
Phase II trial of paclitaxel-epirubicin in patients with recurrent soft-tissue sarcoma. American journal of clinical oncology, 2002, Volume: 25, Issue:6 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Salvage Therapy; Sarcoma; Survival Analysis	2002
Recurrent gastric adenocarcinoma with unusual metastatic localization and excellent response to docetaxel and 5-FU continuous infusion. Onkologie, 2003, Volume: 26, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cisplatin; Docetaxel; Epirubicin; Fluorouracil; Humans; Infusions, Intravenous; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Spleen; Splenic Neoplasms; Stomach Neoplasms; Taxoids; Treatment Outcome	2003
A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder. The Journal of urology, 2004, Volume: 171, Issue:1 Topics: Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Epirubicin; Female; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Time Factors; Urethra; Urinary Bladder Neoplasms	2004
Application of a continual reassessment method to a phase I clinical trial of capecitabine in combination with cyclophosphamide and epirubicin (CEX) for inoperable or recurrent breast cancer. Japanese journal of clinical oncology, 2004, Volume: 34, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Cyclophosphamide; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local	2004
Effect of prophylactic treatment with intravesical epirubicin on recurrence of superficial bladder cancer--The 6th Trial of the Japanese Urological Cancer Research Group (JUCRG): a randomized trial of intravesical epirubicin at dose of 20mg/40ml, 30mg/40m European urology, 2004, Volume: 45, Issue:5 Topics: Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	2004
Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the Mario Negri Institute, British journal of cancer, 2004, Jun-01, Volume: 90, Issue:11 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Disease Progression; Epirubicin; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Survival Analysis; Treatment Outcome	2004
Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancers. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2004, Volume: 30, Issue:6 Topics: Adolescent; Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Chemotherapy, Cancer, Regional Perfusion; Colorectal Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Pelvic Neoplasms; Treatment Outcome	2004
Early and large-dose intravesical instillation of epirubicin to prevent superficial bladder carcinoma recurrence after transurethral resection. BJU international, 2004, Volume: 94, Issue:3 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Urinary Bladder Neoplasms	2004
[Prospective randomized trial of RFA and chemotherapy for unresectable small hepatocellular carcinoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2004, Volume: 26, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheter Ablation; Cisplatin; Combined Modality Therapy; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Ultrasonography, Interventional	2004
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Stem Cell Transplantation; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome	2005
Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Apr-20, Volume: 23, Issue:12 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dactinomycin; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Rhabdomyosarcoma; Teniposide; Treatment Outcome; Vincristine	2005
Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen). Lung cancer (Amsterdam, Netherlands), 2005, Volume: 48, Issue:2 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cross-Over Studies; Cyclophosphamide; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Health Status; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Palliative Care; Prognosis; Treatment Outcome; Vincristine	2005
Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jul-01, Volume: 23, Issue:19 Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Humans; Ifosfamide; Infant; Infant, Newborn; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rhabdomyosarcoma; Sarcoma; Survival Analysis; Teniposide; Vincristine	2005
A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer. Oncology, 2005, Volume: 68, Issue:4-6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Epirubicin; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Stomach Neoplasms; Survival Rate; Treatment Outcome	2005
[Efficacy and safety of different dosages of intravesical epirubicin instillation for prevention of primary superficial bladder carcinoma from recurrence]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2005, Volume: 27, Issue:8 Topics: Administration, Intravesical; Adult; Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Prospective Studies; Urinary Bladder Neoplasms	2005
Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second- or third-line treatment in patients with relapsed ovarian cancer: a phase I/II trial. British journal of cancer, 2006, Jan-16, Volume: 94, Issue:1 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Deoxycytidine; Epirubicin; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Treatment Outcome	2006
Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer. BJU international, 2006, Volume: 97, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine	2006
[Impact of preoperative lymphatic chemotherapy on relapse and metastasis of breast cancer and its mechanism]. Ai zheng = Aizheng = Chinese journal of cancer, 2005, Volume: 24, Issue:12 Topics: Adult; Aged; Antibiotics, Antineoplastic; Apoptosis; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Epirubicin; Fas Ligand Protein; fas Receptor; Female; Humans; Injections, Intralymphatic; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Modified Radical; Middle Aged; Neoplasm Recurrence, Local; Preoperative Care; Single-Blind Method	2005
Epirubicin-docetaxel in advanced gastric cancer: two phase II studies as second and first line treatment. Bulletin du cancer, 2006, Volume: 93, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Docetaxel; Epirubicin; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2006
Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients. International journal of radiation oncology, biology, physics, 2006, Apr-01, Volume: 64, Issue:5 Topics: Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Axilla; Bayes Theorem; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy, Modified Radical; Methotrexate; Middle Aged; Models, Biological; Multivariate Analysis; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Receptors, Estrogen	2006
A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results. International journal of radiation oncology, biology, physics, 2006, Mar-15, Volume: 64, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Confidence Intervals; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Radiotherapy, Adjuvant	2006
Randomized study of single instillation of epirubicin for superficial bladder carcinoma: long-term clinical outcomes. Cancer investigation, 2006, Volume: 24, Issue:2 Topics: Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Epirubicin; Humans; Middle Aged; Neoplasm Recurrence, Local; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms	2006
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial. British journal of cancer, 2006, May-08, Volume: 94, Issue:9 Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Epirubicin; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Analysis; Taxoids	2006
Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and Fluorouracil chemotherapy, surgery, and radiotherapy: long-term results. The oncologist, 2006, Volume: 11, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Survival Rate; Vinblastine	2006
Phase II study of cisplatin plus epirubicin salvage chemotherapy in refractory germ cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Dec-01, Volume: 24, Issue:34 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Epirubicin; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Survival Rate	2006
Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF). BMC cancer, 2006, Dec-05, Volume: 6 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Quality of Life; Stomach Neoplasms; Survival Rate; Taxoids	2006
Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93. Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:7 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Receptors, Estrogen; Tamoxifen	2007
Transarterial infusion chemotherapy with epirubicin in water-in-oil-in-water emulsion for recurrent hepatocellular carcinoma in the residual liver after hepatectomy. European journal of radiology, 2009, Volume: 69, Issue:1 Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Drug Carriers; Emulsions; Epirubicin; Female; Hepatectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Oils; Radiography; Treatment Outcome; Water	2009
A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences. The Journal of urology, 2008, Volume: 179, Issue:1 Topics: Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Cystectomy; Epirubicin; Female; Humans; Male; Neoplasm Recurrence, Local; Prospective Studies; Urethra; Urinary Bladder Neoplasms	2008
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer. British journal of cancer, 2008, Jan-15, Volume: 98, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Female; Humans; Longitudinal Studies; Neoplasm Recurrence, Local; Quality of Life; Quality-Adjusted Life Years; Risk Factors; Survival Rate	2008
Prevention of recurrence with epirubicin and lactobacillus casei after transurethral resection of bladder cancer. The Journal of urology, 2008, Volume: 179, Issue:2 Topics: Administration, Intravesical; Administration, Oral; Aged; Antibiotics, Antineoplastic; Cohort Studies; Combined Modality Therapy; Cystoscopy; Disease-Free Survival; Epirubicin; Female; Humans; Lacticaseibacillus casei; Male; Middle Aged; Neoplasm Recurrence, Local; Probiotics; Urinary Bladder Neoplasms	2008
Salvage chemotherapy with docetaxel and epirubicin for advanced/metastatic gastric cancer. Oncology, 2007, Volume: 73, Issue:1-2 Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hematologic Diseases; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Selection; Platinum Compounds; Salvage Therapy; Severity of Illness Index; Stomach Neoplasms; Taxoids; Treatment Outcome	2007
[Prophylactic intra-arterial chemotherapy for CR patients with invasive bladder cancer after induction therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:11 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Urinary Bladder Neoplasms	1995
[Intravesical instillation of epirubicin hydrochloride in superficial bladder tumor--prophylactic and therapeutic instillation for carcinoma in situ]. Hinyokika kiyo. Acta urologica Japonica, 1995, Volume: 41, Issue:5 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Carcinoma in Situ; Cystitis; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Hemorrhage; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Urinary Bladder Neoplasms	1995
Epirubicin and cisplatin in recurrent, metastatic or advanced carcinoma of the cervix. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22 Suppl 3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Survival Rate; Uterine Cervical Neoplasms	1995
[The role of M-VAC polychemotherapy in the treatment of advanced urothelial carcinoma of the bladder]. Annales d'urologie, 1993, Volume: 27, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Doxorubicin; Epirubicin; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Remission Induction; Urinary Bladder Neoplasms; Vinblastine	1993
Epirubicin, methotrexate and bleomycin in the management of recurrent squamous cell head and neck cancer. A GSTTC randomised phase II study. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Epirubicin; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis	1993
[Intra-arterial infusion chemotherapy for advanced or recurrent breast cancers]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22 Suppl 1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction	1995
Epidoxorubicin and lonidamine in refractory or recurrent epithelial ovarian cancer. European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:10 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance; Epirubicin; Female; Humans; Indazoles; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Salvage Therapy	1994
[Efficacy of intrahepatic arterial chemotherapy to prevent recurrence of residual liver in metastatic liver cancer patients after hepatectomy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:13 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Epirubicin; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual	1994
[Recurrence and survival rate of advanced gastric cancer after preoperative EAP-II intra-arterial infusion therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Humans; Infusions, Intra-Arterial; Neoplasm Metastasis; Neoplasm Recurrence, Local; Preoperative Care; Stomach Neoplasms; Survival Rate	1994
A randomized trial of early intravesical instillation of epirubicin in superficial bladder cancer. The Nagoya University Urological Oncology Group. Cancer chemotherapy and pharmacology, 1994, Volume: 35 Suppl Topics: Administration, Intravesical; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cystoscopy; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	1994
Prophylactic chemotherapy with anthracyclines (adriamycin, epirubicin, and pirarubicin) for primary superficial bladder cancer. The Hokkaido University Bladder Cancer Collaborative Group. Cancer chemotherapy and pharmacology, 1994, Volume: 35 Suppl Topics: Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Regression Analysis; Urinary Bladder Neoplasms	1994
Prospective randomized study of prophylaxis of superficial bladder cancer with epirubicin: the role of a central pathology laboratory. Nara Uro-oncology Research Group. (NUORG). Cancer chemotherapy and pharmacology, 1994, Volume: 35 Suppl Topics: Administration, Intravesical; Aged; Chemotherapy, Adjuvant; Epirubicin; Female; Humans; Longitudinal Studies; Male; Middle Aged; Neoplasm Recurrence, Local; Pathology Department, Hospital; Prognosis; Prospective Studies; Urinary Bladder Neoplasms	1994
Comparison of the prophylactic usefulness of epirubicin and doxorubicin in the treatment of superficial bladder cancer by intravesical instillation: a multicenter randomized trial. Kobe University Urological Oncology Group. Cancer chemotherapy and pharmacology, 1994, Volume: 35 Suppl Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Doxorubicin; Epirubicin; Female; Humans; Longitudinal Studies; Male; Middle Aged; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	1994
Phase II study of intravesical chemoprophylaxis of epirubicin after transurethral resection of bladder tumors. Tottori University Oncology Group. Cancer chemotherapy and pharmacology, 1994, Volume: 35 Suppl Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Epirubicin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	1994
A phase II study of prophylactic intravesical chemotherapy with epirubicin in the treatment of superficial bladder cancer. Tokyo Women's Medical College Bladder Cancer Collaborating Group. Cancer chemotherapy and pharmacology, 1994, Volume: 35 Suppl Topics: Administration, Intravesical; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cystoscopy; Epirubicin; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	1994
A phase II study of prophylactic intravesical chemotherapy with 4'-epirubicin in recurrent superficial bladder cancer: comparison of 4'-epirubicin and adriamycin. Cancer chemotherapy and pharmacology, 1994, Volume: 35 Suppl Topics: Administration, Intravesical; Adult; Aged; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	1994
The effects of intravesical chemoimmunotherapy with epirubicin and bacillus Calmette-Guérin for prophylaxis of recurrence of superficial bladder cancer: a preliminary report. Cancer chemotherapy and pharmacology, 1994, Volume: 35 Suppl Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Combined Modality Therapy; Epirubicin; Female; Follow-Up Studies; Humans; Immunotherapy; Longitudinal Studies; Male; Middle Aged; Mycobacterium bovis; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	1994
Carboplatin plus epirubicin plus VP-16, concurrent 'split course' radiotherapy and adjuvant surgery for limited small cell lung cancer. Gruppo Oncologico Centro-Sud-Isole (GOCSI). Lung cancer (Amsterdam, Netherlands), 1994, Volume: 11, Issue:1-2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Digestive System Diseases; Epirubicin; Etoposide; Humans; Kidney Diseases; Life Tables; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Survival Analysis	1994
[Combination of 5-FU, high dose methotrexate, epirubicin and cisplatin (FEMTX-P protocol) in non surgical or locally recurrent metastatic gastric cancers]. Bulletin du cancer, 1993, Volume: 80, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Stomach Neoplasms; Treatment Outcome	1993
Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-alpha-2b combined with epirubicin: a pilot study. Urological research, 1993, Volume: 21, Issue:5 Topics: Administration, Intravesical; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-1; Interleukin-2; Interleukin-4; Interleukins; Neoplasm Recurrence, Local; Recombinant Proteins; Urinary Bladder Neoplasms	1993
Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: a phase II study of the EORTC Head and Neck Cancer Cooperative Group. Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:9 Topics: Adult; Aged; Carcinoma, Adenoid Cystic; Epirubicin; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local	1993
A plea for cold biopsy, fulguration and immediate bladder instillation with Epirubicin in small superficial bladder tumors. Data from the EORTC GU Group Study 30863. European urology, 1993, Volume: 23, Issue:4 Topics: Administration, Intravesical; Biopsy; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystoscopy; Epirubicin; Humans; Neoplasm Recurrence, Local; Neoplasm Seeding; Urinary Bladder Neoplasms	1993
Intravesical 4'-epi-doxorubicin (epirubicin) versus bacillus Calmette-Guérin. A controlled prospective study on the prophylaxis of superficial bladder cancer. Cancer, 1993, Sep-01, Volume: 72, Issue:5 Topics: Administration, Intravesical; Aged; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystitis; Epirubicin; Female; Follow-Up Studies; Humans; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Remission Induction; Urinary Bladder Neoplasms	1993
A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinom The Journal of urology, 1993, Volume: 149, Issue:4 Topics: Administration, Intravesical; Carcinoma, Transitional Cell; Combined Modality Therapy; Epirubicin; Female; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Prospective Studies; Time Factors; Urinary Bladder Neoplasms; Water	1993
A controlled study of intravesical epirubicin with or without alpha 2b-interferon as prophylaxis for recurrent superficial transitional cell carcinoma of the bladder. Finnish Multicentre Study Group. British journal of urology, 1995, Volume: 76, Issue:6 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neoplasm Recurrence, Local; Recombinant Proteins; Treatment Outcome; Urinary Bladder Neoplasms	1995
Comparison between a cisplatin-containing regimen and a carboplatin-containing regimen for recurrent or metastatic bladder cancer patients. A randomized phase II study. Cancer, 1996, Jan-15, Volume: 77, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Epirubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms; Vinblastine	1996
Results of conservative treatment (transurethral resection plus adjuvant intravesical chemotherapy) in patients with primary T1, G3 transitional cell carcinoma of the bladder. Urology, 1996, Volume: 47, Issue:5 Topics: Administration, Intravesical; Antineoplastic Agents; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxorubicin; Epirubicin; Follow-Up Studies; Humans; Mitomycins; Neoplasm Recurrence, Local; Neoplasm Staging; Surgical Procedures, Operative; Urethra; Urinary Bladder Neoplasms	1996
Intravesical instillation of epirubicin: effect on tumour recurrence in patients with dysplastic epithelium after transurethral resection of superficial bladder tumour. British journal of urology, 1996, Volume: 77, Issue:3 Topics: Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Disease Progression; Disease-Free Survival; Epirubicin; Epithelium; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Risk Factors; Urinary Bladder Neoplasms	1996
5-Fluorouracil, epirubicin, and mitomycin C versus 5-fluorouracil, epirubicin, mitomycin C, and leucovorin in advanced gastric carcinoma. A randomized trial. American journal of clinical oncology, 1996, Volume: 19, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Epirubicin; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Stomach Neoplasms; Survival Rate	1996
Intravesical epirubicin in the prophylaxis of superficial bladder cancer. International urology and nephrology, 1996, Volume: 28, Issue:2 Topics: Administration, Intravesical; Adult; Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Cystectomy; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	1996
[Intra-arterial infusion chemotherapy for breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Neoplasm Recurrence, Local; Prednisolone	1996
Bleomycin, epirubicin, carboplatin (BECA) in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck. Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Epirubicin; Feasibility Studies; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Rate	1997
BCG versus epirubicin in the prophylaxis of multiple superficial bladder tumours: results of a prospective randomized study using modified treatment schemes. International urology and nephrology, 1996, Volume: 28, Issue:4 Topics: Adjuvants, Immunologic; Administration, Intravesical; Aged; Antibiotics, Antineoplastic; BCG Vaccine; Disease-Free Survival; Epirubicin; Female; Humans; Immunotherapy; Male; Neoplasm Recurrence, Local; Prospective Studies; Treatment Outcome; Urinary Bladder Neoplasms	1996
Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: a prospective randomized study. Seminars in oncology, 1997, Volume: 24, Issue:2 Suppl 6 Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Prospective Studies; Survival Rate	1997
Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional-cell bladder tumours: a prospective, randomized controlled study. British journal of urology, 1997, Volume: 79, Issue:5 Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Dose-Response Relationship, Drug; Epirubicin; Female; Follow-Up Studies; Humans; Infant, Newborn; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Urinary Bladder Neoplasms	1997
Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study. The Journal of urology, 1997, Volume: 158, Issue:1 Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Disease Progression; Doxorubicin; Epirubicin; Female; Humans; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Urinary Bladder Neoplasms	1997
[Clinical efficacy of post-TUR prophylactic chemotherapy for superficial bladder cancer--the result of co-operative prospective randomized trial]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:12 Topics: Administration, Intravesical; Administration, Oral; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Cystectomy; Epirubicin; Fluorouracil; Humans; Neoplasm Recurrence, Local; Postoperative Care; Prospective Studies; Urinary Bladder Neoplasms	1997
Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Endometrial Neoplasms; Epirubicin; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Uterine Cervical Neoplasms	1997
Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy. Journal of chemotherapy (Florence, Italy), 1998, Volume: 10, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Extremities; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis	1998
A randomized study of short-versus long-term intravesical epirubicin instillation for superficial bladder cancer. Nagoya University Urological Oncology Group. European urology, 1998, Volume: 33, Issue:3 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Drug Administration Schedule; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Urinary Bladder Neoplasms	1998
Epirubicin has modest single-agent activity in head and neck cancer but limited activity in metastatic melanoma and colorectal cancer: phase II studies by the Eastern Cooperative Oncology Group. American journal of clinical oncology, 1998, Volume: 21, Issue:5 Topics: Adult; Aged; Antibiotics, Antineoplastic; Colorectal Neoplasms; Epirubicin; Female; Head and Neck Neoplasms; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local	1998
[CBDCA, etoposide and epirubicin high-dose combination chemotherapy supported by peripheral blood stem cell transplantation (PBSCT) in metastatic breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local	1999
Transurethral resection with perioperative instilation on interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer: a prospective randomized multicenter study--Finnbladder III. The Journal of urology, 1999, Volume: 161, Issue:4 Topics: Administration, Intravesical; Antineoplastic Agents; Carcinoma, Transitional Cell; Combined Modality Therapy; Epirubicin; Female; Humans; Interferon-alpha; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Urinary Bladder Neoplasms	1999
Intravesical chemotherapy with epirubicin: a dose response study. The Journal of urology, 1999, Volume: 161, Issue:5 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	1999
Dose-intensive first-line chemotherapy with epirubicin and continuous infusion ifosfamide in adult patients with advanced soft tissue sarcomas: a phase II study. European journal of cancer (Oxford, England : 1990), 1999, Volume: 35, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Humans; Ifosfamide; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Sarcoma; Treatment Outcome	1999
Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type. Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Hematologic Diseases; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycins; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Survival Rate	1999
[Effect of prophylactic treatment with intravesical epirubicin in recurrence of superficial bladder tumor]. Archivos espanoles de urologia, 1999, Volume: 52, Issue:4 Topics: Administration, Intravesical; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Epirubicin; Humans; Middle Aged; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	1999
Proliferating fraction during neoadjuvant chemotherapy of primary breast cancer in relation to objective local response and relapse-free survival. Acta oncologica (Stockholm, Sweden), 1999, Volume: 38, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Ki-67 Antigen; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Patient Selection; Predictive Value of Tests; Prognosis; Treatment Outcome	1999
Investigating centre effects in a multi-centre clinical trial of superficial bladder cancer. Statistics in medicine, 1999, Aug-15, Volume: 18, Issue:15 Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Clinical Trials as Topic; Epirubicin; Humans; Likelihood Functions; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Proportional Hazards Models; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms	1999
Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type. Cancer, 1999, Oct-01, Volume: 86, Issue:7 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Radiotherapy; Survival Rate; Treatment Outcome	1999
Combination of epirubicin and cisplatin in hormone-refractory metastatic prostate cancer. American journal of clinical oncology, 1999, Volume: 22, Issue:5 Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance, Neoplasm; Epirubicin; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Treatment Outcome	1999
Epirubicin plus tamoxifen versus tamoxifen alone in node-positive postmenopausal patients with breast cancer: A randomized trial of the International Collaborative Cancer Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:7 Topics: Adult; Age Factors; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Epirubicin; Female; Humans; London; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Paris; Postmenopause; Proportional Hazards Models; Survival Rate; Tamoxifen	1999
Three new active cisplatin-containing combinations in the neoadjuvant treatment of locally advanced and locally recurrent breast carcinoma: a randomized phase II trial. Breast cancer research and treatment, 1999, Volume: 56, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Epirubicin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Vincristine	1999
Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas. Journal of Korean medical science, 1999, Volume: 14, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Humans; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Rate; Treatment Failure; Vincristine	1999
Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients. Journal of cancer research and clinical oncology, 1999, Volume: 125, Issue:12 Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Dactinomycin; Drug Resistance, Neoplasm; Drug Therapy, Combination; Epirubicin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Salvage Therapy; Testicular Neoplasms; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine	1999
Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest. Gynecologic oncology, 2000, Volume: 76, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Epirubicin; Female; Humans; Infusions, Intravenous; Infusions, Parenteral; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Reoperation; Survival Analysis	2000
Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma. World journal of surgery, 2000, Volume: 24, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Case-Control Studies; Chemotherapy, Adjuvant; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Prospective Studies; Survival Rate	2000
Clinical experience with BCG alone versus BCG plus epirubicin. International journal of urology : official journal of the Japanese Urological Association, 2000, Volume: 7, Issue:6 Topics: Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Combined Modality Therapy; Epirubicin; Female; Follow-Up Studies; Humans; Immunotherapy; Male; Middle Aged; Mycobacterium bovis; Neoplasm Recurrence, Local; Treatment Outcome; Urinary Bladder Neoplasms	2000
[Continuous intravesical instillation of epirubicin immediately after transurethral resection of superficial bladder cancer: a prospective controlled study]. Hinyokika kiyo. Acta urologica Japonica, 2000, Volume: 46, Issue:5 Topics: Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Perioperative Care; Premedication; Prospective Studies; Therapeutic Irrigation; Urinary Bladder Neoplasms	2000
Alpha 2-b interferon and farmarubicin in the prophylaxis of recurrence of superficial transitional cell carcinoma of the urinary bladder. Bratislavske lekarske listy, 2000, Volume: 101, Issue:6 Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Epirubicin; Humans; Interferon alpha-2; Interferon-alpha; Neoplasm Recurrence, Local; Recombinant Proteins; Urinary Bladder Neoplasms	2000
[Intra-arterial preoperative chemotherapy versus preoperative radiotherapy]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2001, Volume: 177, Issue:2 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Carotid Artery, External; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Epirubicin; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Mouth Floor; Mouth Neoplasms; Neoplasm Recurrence, Local; Odds Ratio; Osteoradionecrosis; Preoperative Care; Quality of Life; Radiotherapy; Radiotherapy Dosage; Radiotherapy, Adjuvant; Surveys and Questionnaires; Time Factors; Tongue Neoplasms	2001
Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy. Cancer research, 2001, Feb-15, Volume: 61, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Tamoxifen; Thymidine Kinase; Thymidylate Synthase	2001
Second-line therapy for potentially platinum-sensitive recurrent ovarian cancer: what is optimal treatment? Gynecologic oncology, 2001, Volume: 81, Issue:1 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Disease-Free Survival; Epirubicin; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Randomized Controlled Trials as Topic	2001
Local hyperthermia, radiation, and chemotherapy in recurrent breast cancer is feasible and effective except for inflammatory disease. International journal of radiation oncology, biology, physics, 2001, Apr-01, Volume: 49, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Epirubicin; Feasibility Studies; Female; Humans; Hyperthermia, Induced; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy Dosage	2001
Vinorelbine, epirubicin, and methotrexate (VEM) as primary treatment in locally advanced breast cancer. The oncologist, 2001, Volume: 6, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Epirubicin; Female; Humans; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine	2001
Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Nov-15, Volume: 19, Issue:22 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Mastectomy, Radical; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Preoperative Care; Quality of Life; Receptors, Estrogen; Survival Rate	2001
Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy. British journal of cancer, 2001, Nov-16, Volume: 85, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Epirubicin; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome	2001
Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Dec-01, Volume: 19, Issue:23 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Analysis; Taiwan; Treatment Outcome	2001
[Intravesical instillation of doxorubicin or epirubicin for chemoprophylaxis of superficial bladder cancer--the fifth study of the Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:1 Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Epirubicin; Female; Humans; Instillation, Drug; Male; Neoplasm Recurrence, Local; Postoperative Care; Urinary Bladder Neoplasms	2002
Deliberate hypoxic pelvic and limb chemoperfusion in the treatment of recurrent melanoma. American journal of surgery, 2002, Volume: 183, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Dacarbazine; Disease Progression; Disease-Free Survival; Epirubicin; Female; Hemodynamics; Humans; Hypoxia; Leg; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Pelvis; Skin Neoplasms; Treatment Outcome	2002
Treatment of refractory Hodgkin's disease with modified Stanford V program. Medical oncology (Northwood, London, England), 2001, Volume: 18, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Salvage Therapy; Survival Analysis; Vinblastine; Vincristine	2001
[Single instillation of epirubicin for the prophylaxis of recurrent primary superficial bladder carcinoma]. Zhonghua wai ke za zhi [Chinese journal of surgery], 2002, Volume: 40, Issue:2 Topics: Aged; Antibiotics, Antineoplastic; Epirubicin; Feasibility Studies; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	2002
Intravesical therapy with adriamycin and 4-epirubicin for superficial bladder cancer: the experience of the EORTC GU Group. Cancer chemotherapy and pharmacology, 1992, Volume: 30 Suppl Topics: Administration, Intravesical; Chemotherapy, Adjuvant; Doxorubicin; Epirubicin; Ethoglucid; Humans; Neoplasm Recurrence, Local; Prospective Studies; Urinary Bladder Neoplasms	1992
Randomized trial of adjuvant chemotherapy for operable breast cancer comparing i.v. CMF to an epirubicin-containing regimen [see comment]. Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:6 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Injections, Intravenous; Methotrexate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Thiotepa; Vincristine; Vindesine	1992
4'-epidoxorubicin versus mitomycin C intravesical chemoprophylaxis of superficial bladder cancer. European urology, 1992, Volume: 21, Issue:1 Topics: Administration, Intravesical; Aged; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Epirubicin; Female; Follow-Up Studies; Humans; Male; Mitomycin; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	1992
Chemoimmunotherapy for prophylaxis of recurrence in superficial bladder cancer: interferon-alpha 2b versus interferon-alpha 2b with epirubicin. Anti-cancer drugs, 1992, Volume: 3 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Male; Neoplasm Recurrence, Local; Recombinant Proteins; Urinary Bladder Neoplasms	1992
Intravesical instillations of 4-epi-doxorubicin (epirubicin) in the prophylactic treatment of superficial bladder cancer: results of a controlled prospective study. The Journal of urology, 1992, Volume: 147, Issue:2 Topics: Administration, Intravesical; Aged; Carcinoma, Transitional Cell; Epirubicin; Female; Humans; Male; Neoplasm Recurrence, Local; Prospective Studies; Urinary Bladder Neoplasms	1992
Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre. Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2, Issue:5 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Protocols; Epirubicin; Female; Humans; Lymph Node Excision; Mastectomy; Methotrexate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Thiotepa; Vincristine; Vindesine	1991
Intravesical epirubicin with and without verapamil for the prophylaxis of superficial bladder tumours. Scandinavian journal of urology and nephrology, 1991, Volume: 25, Issue:1 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Drug Synergism; Electrocoagulation; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms; Verapamil	1991
A randomized pilot study of high-dose epirubicin as neoadjuvant chemotherapy in the treatment of cancer of the bilharzial bladder. Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2, Issue:2 Topics: Adult; Carcinoma; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Epirubicin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Postoperative Complications; Schistosomiasis; Survival Rate; Urinary Bladder Neoplasms	1991
Multi-centre phase II study of low dose intravesical epirubicin in the treatment of superficial bladder cancer. Yorkshire and Scottish Urological Cancer Research Groups. British journal of urology, 1991, Volume: 67, Issue:6 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Urinary Bladder Neoplasms	1991
High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: a phase II study. Annals of oncology : official journal of the European Society for Medical Oncology, 1990, Volume: 1, Issue:5 Topics: Combined Modality Therapy; Drug Administration Schedule; Drug Evaluation; Epirubicin; Humans; Male; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Testicular Neoplasms	1990
[Phase II study of epirubicin in inoperable or recurrent gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:5 Topics: Adult; Aged; Anemia; Anorexia; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Stomach Neoplasms; Thrombocytopenia	1986
[A prospective randomized trial comparing epirubicin and doxorubicin in advanced or recurrent breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:12 Topics: Adult; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Menopause; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Random Allocation	1986

Other Studies

194 other study(ies) available for epirubicin and Local Neoplasm Recurrence

Article	Year
Safety and Efficacy of Glass Membrane Pumping Emulsification Device in Transarterial Chemoembolization for Hepatocellular Carcinoma: First Clinical Outcomes. Anticancer research, 2021, Volume: 41, Issue:11 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Drug Delivery Systems; Emulsions; Epirubicin; Equipment Design; Ethiodized Oil; Female; Glass; Humans; Liver Neoplasms; Male; Membranes, Artificial; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Time Factors; Treatment Outcome; Tumor Burden	2021
Molecular classification of patients with NMIBC predicts the efficacy of intravesical chemotherapy with pirarubicin, pharmorubicin and gemcitabine-immunohistochemistry-based classification. Japanese journal of clinical oncology, 2022, May-31, Volume: 52, Issue:6 Topics: Administration, Intravesical; Anthracyclines; Antibiotics, Antineoplastic; Deoxycytidine; Doxorubicin; Epirubicin; Gemcitabine; Humans; Immunohistochemistry; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	2022
Study of epirubicin sustained-release chemoablation in tumor suppression and tumor microenvironment remodeling. Frontiers in immunology, 2022, Volume: 13 Topics: Animals; Delayed-Action Preparations; Drug Carriers; Epirubicin; Hydrogels; Immunotherapy; Mice; Neoplasm Recurrence, Local; Programmed Cell Death 1 Receptor; Tumor Microenvironment	2022
Evaluation of thermal dose effect in radiofrequency-induced hyperthermia with intravesical chemotherapy for nonmuscle invasive bladder cancer. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2023, Volume: 40, Issue:1 Topics: Combined Modality Therapy; Epirubicin; Humans; Hyperthermia, Induced; Mitomycin; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	2023
Long-term prevention of bladder cancer progression by alpha1-oleate alone or in combination with chemotherapy. International journal of cancer, 2023, Aug-01, Volume: 153, Issue:3 Topics: Animals; Antibiotics, Antineoplastic; Epirubicin; Mice; Mitomycin; Neoplasm Recurrence, Local; Oleic Acid; Urinary Bladder; Urinary Bladder Neoplasms	2023
Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence. BMC urology, 2019, Oct-15, Volume: 19, Issue:1 Topics: Aged; Anthracyclines; Antineoplastic Agents; Deoxycytidine; Doxorubicin; Epirubicin; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms	2019
Clinical outcome and predictive factors for docetaxel and epirubicin neoadjuvant chemotherapy of locally advanced breast cancer. The Korean journal of internal medicine, 2020, Volume: 35, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Epirubicin; Female; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Retrospective Studies; Taxoids; Treatment Outcome; Young Adult	2020
[A Case of Locally Advanced Breast Cancer Successfully Treated with Epirubicin/Cyclophosphamide]. Gan to kagaku ryoho. Cancer & chemotherapy, 2019, Volume: 46, Issue:13 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Humans; Neoplasm Recurrence, Local	2019
Transformation of NSCLC to SCLC after 1st- and 3rd-generation EGFR-TKI resistance and response to EP regimen and erlotinib: 2 CARE-compliant case reports. Medicine, 2021, Mar-12, Volume: 100, Issue:10 Topics: Acrylamides; Adult; Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Resistance, Neoplasm; Epirubicin; ErbB Receptors; Erlotinib Hydrochloride; Fatal Outcome; Female; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Protein Kinase Inhibitors; Small Cell Lung Carcinoma; Tomography, X-Ray Computed; Treatment Outcome	2021
Vimentin Promotes the Aggressiveness of Triple Negative Breast Cancer Cells Surviving Chemotherapeutic Treatment. Cells, 2021, 06-15, Volume: 10, Issue:6 Topics: Animals; Cell Line, Tumor; Cell Movement; Cyclophosphamide; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Therapy; Epirubicin; Epithelial-Mesenchymal Transition; Female; Humans; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Paclitaxel; Triple Negative Breast Neoplasms; Vimentin; Zebrafish	2021
Comparison of Efficacy of Adjuvant MEC (Methotrexate, Epirubicin and Cisplatin) and GC (Gemcitabine and Cisplatin) in Advanced Upper Tract Urothelial Carcinoma. Anticancer research, 2017, Volume: 37, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Risk Factors; Survival Rate; Urologic Neoplasms	2017
Epithelial-mesenchymal transition induced by GRO-α-CXCR2 promotes bladder cancer recurrence after intravesical chemotherapy. Oncotarget, 2017, Jul-11, Volume: 8, Issue:28 Topics: Administration, Intravesical; Animals; Chemokine CXCL1; Epirubicin; Epithelial-Mesenchymal Transition; Female; HEK293 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Recurrence, Local; Random Allocation; Receptors, Interleukin-8B; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays	2017
Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma. Annals of surgical oncology, 2017, Volume: 24, Issue:8 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carboplatin; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Perioperative Care; Preoperative Care; Prognosis; Prospective Studies; Retrospective Studies; Stomach Neoplasms; Survival Rate	2017
[Clinical investigation on transarterial chemoembolization with indigenous drug-eluting beads in treatment of unresectable hepatocellular carcinoma]. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2017, 01-25, Volume: 46, Issue:1 Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Comparative Effectiveness Research; Drug Delivery Systems; Epirubicin; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Microspheres; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome	2017
Epirubicin suppresses proliferative and metastatic potential by downregulating transforming growth factor-β-induced expression in urothelial carcinoma. Cancer science, 2018, Volume: 109, Issue:4 Topics: Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Epirubicin; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; RNA, Messenger; Transforming Growth Factor beta; Up-Regulation; Urologic Neoplasms; Urothelium	2018
Taxane Followed by Anthracycline or Vice Versa: Impact of Sequential Order on Breast Cancer Recurrence?-Reply. JAMA oncology, 2018, 03-01, Volume: 4, Issue:3 Topics: Anthracyclines; Breast Neoplasms; Bridged-Ring Compounds; Capecitabine; Cyclophosphamide; Docetaxel; Epirubicin; Humans; Neoplasm Recurrence, Local; Taxoids	2018
Taxane Followed by Anthracycline or Vice Versa: Impact of Sequential Order on Breast Cancer Recurrence? JAMA oncology, 2018, 03-01, Volume: 4, Issue:3 Topics: Anthracyclines; Breast Neoplasms; Bridged-Ring Compounds; Capecitabine; Cyclophosphamide; Docetaxel; Epirubicin; Humans; Neoplasm Recurrence, Local; Taxoids	2018
Update on the role of endovesical chemotherapy in nonmuscle-invasive bladder cancer. Actas urologicas espanolas, 2018, Volume: 42, Issue:2 Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Combined Modality Therapy; Doxorubicin; Epirubicin; Humans; Mitomycin; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Practice Guidelines as Topic; Urinary Bladder Neoplasms	2018
Efficacy of intra-arterial chemotherapy combined with intravesical chemotherapy in T1G3 bladder cancer when compared with intravesical chemotherapy alone after bladder-sparing surgery: a retrospective study. World journal of urology, 2019, Volume: 37, Issue:5 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystoscopy; Doxorubicin; Epirubicin; Female; Humans; Injections, Intra-Arterial; Male; Middle Aged; Neoplasm Recurrence, Local; Organ Sparing Treatments; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms	2019
The Role of Continuing Perioperative Chemotherapy Post Surgery in Patients with Esophageal or Gastroesophageal Junction Adenocarcinoma: a Multicenter Cohort Study. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2019, Volume: 23, Issue:9 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Humans; Male; Margins of Excision; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm, Residual; Perioperative Period; Propensity Score; Retrospective Studies; Survival Rate	2019
[A Case of Drug-Induced Interstitial Lung Disease Associated with Epirubicin and Cyclophosphamide Therapy before Operation]. Gan to kagaku ryoho. Cancer & chemotherapy, 2019, Volume: 46, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Humans; Lung Diseases, Interstitial; Mastectomy; Middle Aged; Neoplasm Recurrence, Local	2019
Intra-arterial chemotherapy combined with intravesical chemotherapy is effective in preventing recurrence in non-muscle invasive bladder cancer. Journal of cancer research and clinical oncology, 2019, Volume: 145, Issue:6 Topics: Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Cystectomy; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Retrospective Studies; Urinary Bladder Neoplasms	2019
A suspected case of Clostridium perfringens sepsis with intravascular hemolysis after transhepatic arterial chemoembolization: a case report. Journal of medical case reports, 2019, Apr-27, Volume: 13, Issue:1 Topics: Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Clostridium perfringens; Embolization, Therapeutic; Epirubicin; Fatal Outcome; Hemolysis; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Sepsis	2019
Risk factors for local recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE). Japanese journal of radiology, 2019, Volume: 37, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Epirubicin; Female; Humans; Iohexol; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiographic Image Enhancement; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome	2019
Prognosis of patients with hepatocellular carcinoma treated solely with transcatheter arterial chemoembolization: risk factors for one-year recurrence and two-year mortality (preliminary data). Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:8 Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheterization, Peripheral; Cohort Studies; Embolization, Therapeutic; Epirubicin; Female; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome	2013
Adjuvant trastuzumab for 6 months is effective in patients with HER2-positive stage II or III breast cancer. Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:3 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Immunoenzyme Techniques; In Situ Hybridization, Fluorescence; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Receptor, ErbB-2; Retrospective Studies; Survival Rate; Taxoids; Trastuzumab	2013
Eradication of breast cancer with bone metastasis by autologous formalin-fixed tumor vaccine (AFTV) combined with palliative radiation therapy and adjuvant chemotherapy: a case report. World journal of surgical oncology, 2013, Jun-04, Volume: 11 Topics: Anastrozole; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Autoantigens; Bone Neoplasms; Breast Neoplasms; Cancer Vaccines; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Diphosphonates; Epirubicin; Female; Fixatives; Fluorouracil; Formaldehyde; Humans; Imidazoles; Magnetic Resonance Imaging; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Prognosis; Radiotherapy Dosage; Tomography, Emission-Computed, Single-Photon; Triazoles; Zoledronic Acid	2013
Shrink pattern of breast cancer after neoadjuvant chemotherapy and its correlation with clinical pathological factors. World journal of surgical oncology, 2013, Jul-24, Volume: 11, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Epirubicin; Female; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Paclitaxel; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone	2013
Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience. International journal of radiation oncology, biology, physics, 2013, Nov-15, Volume: 87, Issue:4 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Retrospective Studies; Rituximab; Skin Neoplasms; Treatment Outcome; Vincristine	2013
The postoperative component of MAGIC chemotherapy is associated with improved prognosis following surgical resection in gastric and gastrooesophageal junction adenocarcinomas. International journal of surgical oncology, 2013, Volume: 2013 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Risk Factors; Stomach Neoplasms	2013
The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction. Journal of surgical oncology, 2014, Volume: 109, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anastomotic Leak; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Databases, Factual; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorouracil; Gastrectomy; Hospitals, University; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Predictive Value of Tests; Prognosis; Prospective Studies; Stomach Neoplasms; United Kingdom	2014
Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus. World journal of gastroenterology, 2013, Dec-28, Volume: 19, Issue:48 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Endosonography; England; Epirubicin; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Hospital Mortality; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2013
Comparison of efficacy and toxicity of first line chemotherapy with or without epirubicin for patients with advanced stage soft tissue sarcoma. Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:12 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Deoxycytidine; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Retrospective Studies; Sarcoma; Survival Rate; Young Adult	2013
Impact of neoadjuvant chemotherapy with PELF-protocoll versus surgery alone in the treatment of advanced gastric carcinoma. BMC surgery, 2014, Jan-24, Volume: 14 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Gastrectomy; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Analysis; Treatment Outcome	2014
The Impact of Positive Margins on Outcome Among Patients With Gastric Cancer Treated With Radiation. American journal of clinical oncology, 2016, Volume: 39, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Epirubicin; Female; Gastrectomy; Humans; Lymphatic Metastasis; Male; Margins of Excision; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Stomach Neoplasms; Survival Rate	2016
A nomogram for predicting locoregional recurrence in primary breast cancer patients who received breast-conserving surgery after neoadjuvant chemotherapy. Journal of surgical oncology, 2014, Volume: 109, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Nomograms; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; ROC Curve; Survival Rate; Taxoids	2014
Combined chemohyperthermia: 10-year single center experience in 160 patients with nonmuscle invasive bladder cancer. The Journal of urology, 2014, Volume: 192, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Female; Humans; Hyperthermia, Induced; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Prospective Studies; Time Factors; Urinary Bladder Neoplasms	2014
Taxane and anthracycline based neoadjuvant chemotherapy for locally advanced breast cancer: institutional experience. Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:5 Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Docetaxel; Epirubicin; Female; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Retrospective Studies; Taxoids; Treatment Outcome; Young Adult	2014
Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma Epstein-Barr virus deoxyribonucleic acid. International journal of radiation oncology, biology, physics, 2014, May-01, Volume: 89, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Chemotherapy, Adjuvant; Cisplatin; DNA, Viral; Drug Combinations; Epirubicin; Female; Fluorouracil; Herpesvirus 4, Human; Humans; Induction Chemotherapy; Leucovorin; Male; Middle Aged; Mitomycin; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Radiotherapy, Conformal; Retrospective Studies; Tegafur; Treatment Outcome; Uracil	2014
Outcomes in gastric and junctional cancer using neoadjuvant and adjuvant chemotherapy (epirubicin, oxaliplatin, and capecitabine) and radical surgery. Irish journal of medical science, 2015, Volume: 184, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Epirubicin; Esophagogastric Junction; Female; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Stomach Neoplasms; Survival Rate; Treatment Outcome	2015
BRCA2-associated therapy-related acute myeloid leukemia. Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Genes, BRCA2; Humans; Leukemia, Myeloid, Acute; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Taxoids	2015
Coencapsulation of epirubicin and metformin in PEGylated liposomes inhibits the recurrence of murine sarcoma S180 existing CD133+ cancer stem-like cells. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2014, Volume: 88, Issue:3 Topics: AC133 Antigen; Animals; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Carriers; Drug Compounding; Epirubicin; Glycoproteins; Liposomes; Male; Metformin; Mice, Inbred Strains; Microscopy, Electron, Transmission; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neoplastic Stem Cells; Peptides; Polyethylene Glycols; Sarcoma 180; Surface Properties	2014
Ifosfamide-containing regimens for treating patients with osteosarcomas. Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:22 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Epirubicin; Follow-Up Studies; Humans; Ifosfamide; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Prognosis; Survival Rate	2014
Addition of epirubicin to conventional chemotherapy in patients with advanced ovarian cancer: sequential therapy -a retrospective evaluation. . Turkish journal of medical sciences, 2014, Volume: 44, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Cisplatin; Cytoreduction Surgical Procedures; Disease-Free Survival; Epirubicin; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Young Adult	2014
Ablative Intravesical Chemotherapy for Small Recurrent Non-Muscle-Invasive Bladder Cancer: A Prospective Study. Urologia internationalis, 2016, Volume: 96, Issue:1 Topics: Administration, Intravesical; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Combined Modality Therapy; Cystoscopy; Disease-Free Survival; Epirubicin; Female; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Treatment Outcome; Urinary Bladder Neoplasms	2016
Bevacizumab combined with chemotherapy in the treatment of recurrence or platinum-refractory ovarian cancer: a retrospective study of 37 cases. Indian journal of cancer, 2014, Volume: 51 Suppl 3 Topics: Adenocarcinoma, Papillary; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Transitional Cell; Cystadenocarcinoma, Serous; Deoxycytidine; Drug Resistance, Neoplasm; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate	2014
Epirubicin plus paclitaxel regimen as second-line treatment of patients with small-cell lung cancer. Anticancer research, 2015, Volume: 35, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug-Related Side Effects and Adverse Reactions; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Small Cell Lung Carcinoma	2015
Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification. The oncologist, 2015, Volume: 20, Issue:6 Topics: Adult; Aged; Chemoembolization, Therapeutic; Cholangiocarcinoma; Enbucrilate; Epirubicin; Female; Fluorouracil; Hepatectomy; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Risk Factors	2015
Analysis of Japanese Patients Treated with or without Long-Term Epirubicin Plus Ara-C Intravesical Instillation Therapy for Low-Grade Superficial Bladder Cancer. TheScientificWorldJournal, 2015, Volume: 2015 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease Progression; Epirubicin; Female; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Treatment Outcome; Urinary Bladder Neoplasms	2015
Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer. International urology and nephrology, 2015, Volume: 47, Issue:9 Topics: Adjuvants, Immunologic; Administration, Intravesical; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; BCG Vaccine; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystectomy; Cystoscopy; Disease Progression; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Natural Orifice Endoscopic Surgery; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Survival Rate; Treatment Outcome; Urethra; Urinary Bladder Neoplasms	2015
A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer. Clinical breast cancer, 2016, Volume: 16, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Genotype; Glucuronosyltransferase; Humans; Immunoenzyme Techniques; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Polymorphism, Single Nucleotide; Prognosis; Prospective Studies; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate	2016
¹⁸F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:4 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Treatment Outcome; Triple Negative Breast Neoplasms	2016
Successful Preoperative Chemoembolization in the Treatment of a Giant Malignant Phyllodes Tumor. Cardiovascular and interventional radiology, 2016, Volume: 39, Issue:7 Topics: Adult; Breast Neoplasms; Chemoembolization, Therapeutic; Combined Modality Therapy; Embolization, Therapeutic; Epirubicin; Female; Humans; Mastectomy; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Phyllodes Tumor	2016
Safety Analysis of Adjuvant Chemotherapy with Docetaxel Administered with or without Anthracyclines to Early Stage Breast Cancer Patients: Combined Results from the Asia- Pacific Breast Initiatives I and II. Asian Pacific journal of cancer prevention : APJCP, 2016, Volume: 17, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Docetaxel; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; Longitudinal Studies; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Safety; Survival Rate; Taxoids; Young Adult	2016
Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma. International journal of nanomedicine, 2016, Volume: 11 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blood-Brain Barrier; Brain Neoplasms; Caspase 8; Celecoxib; Cell Line, Tumor; Epirubicin; Glioma; Humans; Liposomes; Male; Mice, Nude; Neoplasm Recurrence, Local	2016
Has serum CA 125 assay at the time of relapse a prognostic relevance for patients with recurrent ovarian carcinoma after primary cytoreduction and platinum- and paclitaxel-based chemotherapy? European journal of gynaecological oncology, 2016, Volume: 37, Issue:2 Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; CA-125 Antigen; Carboplatin; Carcinoma; Carcinoma, Endometrioid; Cohort Studies; Cytoreduction Surgical Procedures; Epirubicin; Female; Humans; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Cystic, Mucinous, and Serous; Ovarian Neoplasms; Paclitaxel; Prognosis; Retrospective Studies	2016
Prognostic Value of 68Ga-NOTA-RGD PET/CT for Predicting Disease-Free Survival for Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy and Surgery: A Comparison Study With Dynamic Contrast Enhanced MRI. Clinical nuclear medicine, 2016, Volume: 41, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Contrast Media; Coordination Complexes; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Epirubicin; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Kaplan-Meier Estimate; Lymph Node Excision; Magnetic Resonance Imaging; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Taxoids	2016
Dose-Modified Ifosfamide, Epirubicin, and Etoposide is a Safe and Effective Salvage Therapy with High Peripheral Blood Stem Cell Mobilization Capacity for Poorly Mobilized Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma Patients. Journal of clinical and experimental hematopathology : JCEH, 2016, Volume: 56, Issue:1 Topics: Antigens, CD34; Antineoplastic Agents; Epirubicin; Etoposide; Hematopoietic Stem Cell Mobilization; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Peripheral Blood Stem Cells; Prospective Studies; Salvage Therapy	2016
Re: Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-α2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study. European urology, 2017, Volume: 71, Issue:1 Topics: Adjuvants, Immunologic; Administration, Intravesical; Bacillus; BCG Vaccine; Epirubicin; Humans; Neoplasm Recurrence, Local; Urinary Bladder; Urinary Bladder Neoplasms	2017
Intravesical chemotherapy use after radical nephroureterectomy: A national survey of urologic oncologists. Urologic oncology, 2017, Volume: 35, Issue:3 Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Doxorubicin; Epirubicin; Humans; Instillation, Drug; Kidney Neoplasms; Mitomycin; Neoplasm Recurrence, Local; Nephroureterectomy; Oncologists; Perioperative Care; Retrospective Studies; Surveys and Questionnaires; Thiotepa; Ureteral Neoplasms; Urinary Bladder Neoplasms	2017
MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib. British journal of cancer, 2017, Mar-14, Volume: 116, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Epirubicin; ErbB Receptors; Erlotinib Hydrochloride; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Matrix Metalloproteinases, Membrane-Associated; Mice; Mice, Nude; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays	2017
Platinum-based chemotherapy in triple-negative breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Vinblastine	2008
Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases. Scandinavian journal of urology and nephrology, 2008, Volume: 42, Issue:6 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Biopsy; Chemotherapy, Adjuvant; Cystectomy; Cystoscopy; Dose-Response Relationship, Drug; Epirubicin; Female; Follow-Up Studies; Humans; Incidence; Instillation, Drug; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Care; Prospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Young Adult	2008
New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients. Journal of the National Cancer Institute, 2008, Aug-06, Volume: 100, Issue:15 Topics: Adult; Age Factors; Aged; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Denmark; Disease Susceptibility; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Heart; Heart Failure; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Severity of Illness Index; Tamoxifen; Vindesine	2008
Weekly epirubicin in the treatment of gestational breast cancer (GBC). Breast cancer research and treatment, 2009, Volume: 115, Issue:3 Topics: Adult; Antibiotics, Antineoplastic; Breast Neoplasms; Epirubicin; Female; Gestational Age; Humans; Infant, Newborn; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prognosis; Survival Rate	2009
Re: A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences: I. Berrum-svennung, T. Granfors, S. Jahnson, H. Boman and S. Holmang. J Urol 2008; 179: 101-106. The Journal of urology, 2008, Volume: 180, Issue:5 Topics: Administration, Intravesical; Cystectomy; Cystoscopy; Dose-Response Relationship, Drug; Epirubicin; Female; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Postoperative Care; Risk Assessment; Treatment Outcome; Urinary Bladder Neoplasms	2008
[Analysis of the diagnosis and treatment of cervical minimal deviation adenocarcinoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2008, Volume: 30, Issue:10 Topics: Actins; Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Cervix Uteri; Chemotherapy, Adjuvant; Cisplatin; Conization; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Papanicolaou Test; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms; Vaginal Smears	2008
What is the optimal treatment strategy for T1 bladder tumors? European urology, 2010, Volume: 57, Issue:1 Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma; Cystectomy; Disease Progression; Disease-Free Survival; Epirubicin; Humans; Interferon alpha-2; Interferon-alpha; Neoplasm Recurrence, Local; Neoplasm Staging; Practice Guidelines as Topic; Recombinant Proteins; Reoperation; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Tumor Burden; Urinary Bladder Neoplasms	2010
Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy? The Journal of urology, 2010, Volume: 183, Issue:1 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Combined Modality Therapy; Epirubicin; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Nephrectomy; Postoperative Care; Retrospective Studies; Time Factors; Ureter; Ureteral Neoplasms; Young Adult	2010
Editorial comment. The Journal of urology, 2010, Volume: 183, Issue:1 Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Combined Modality Therapy; Epirubicin; Humans; Kidney Neoplasms; Mitomycin; Neoplasm Recurrence, Local; Nephrectomy; Postoperative Care; Ureter; Ureteral Neoplasms	2010
Concurrent chemoradiation followed by adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma in Korea. Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:4 Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease Progression; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Epirubicin; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymph Nodes; Male; Middle Aged; Nasopharyngeal Neoplasms; Nasopharynx; Neoplasm Recurrence, Local; Patient Compliance; Republic of Korea; Survival Analysis; Young Adult	2010
Early distant relapse in early stage triple-negative breast cancer: usefulness of FDG-PET for diagnosis of distant metastases. Breast cancer (Tokyo, Japan), 2013, Volume: 20, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Mastectomy, Segmental; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone	2013
Acute promyelocytic leukemia in a young patient with breast cancer. Medical oncology (Northwood, London, England), 2011, Volume: 28, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Leukemia, Promyelocytic, Acute; Leukemia, Radiation-Induced; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Radiotherapy; Treatment Outcome	2011
[Cerebral radionecrosis after irradiation of a cancer of the cavum]. Revue neurologique, 2009, Volume: 165 Spec No 3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Injury, Chronic; Brain Stem; Carcinoma; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Diagnosis, Differential; Epirubicin; Female; Gait Disorders, Neurologic; Humans; Hypesthesia; Magnetic Resonance Imaging; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paresis; Radiation Injuries; Temporal Lobe	2009
[Pediatric nasopharyngeal carcinoma: Anatomoclinic aspects, therapeutic results and evolutive particularities]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2010, Volume: 14, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Chemotherapy, Adjuvant; Child; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radioisotope Teletherapy; Radiotherapy, Conformal; Retrospective Studies; Treatment Outcome; Xerostomia; Young Adult	2010
Second-line chemotherapy for advanced or recurrent endometrial carcinoma previously treated with paclitaxel and carboplatin, with or without epirubicin. Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Endometrial Neoplasms; Epirubicin; Female; Humans; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Paclitaxel; Retrospective Studies; Time Factors; Treatment Outcome	2011
Prospective comparison of transcatheter arterial chemoembolization with Lipiodol-epirubicin and Lipiodol-cisplatin for treatment of recurrent hepatocellular carcinoma. Japanese journal of radiology, 2010, Volume: 28, Issue:5 Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Treatment Outcome	2010
Is radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy? International journal of radiation oncology, biology, physics, 2011, Apr-01, Volume: 79, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Irradiation; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Thiotepa; Tumor Burden; Young Adult	2011
Transcatheter infusion of epirubicin in water-in-oil-in-water emulsion via a cystic artery for the treatment of hepatocellular carcinoma. Cardiovascular and interventional radiology, 2011, Volume: 34, Issue:4 Topics: Aged; Aged, 80 and over; Angiography; Antibiotics, Antineoplastic; Arteries; Carcinoma, Hepatocellular; Delayed-Action Preparations; Emulsions; Epirubicin; Ethiodized Oil; Female; Humans; Image Processing, Computer-Assisted; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Retreatment; Tomography, X-Ray Computed	2011
[Early stage breast cancer: is exclusive radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2011, Volume: 15, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Remission Induction; Survival Analysis; Tumor Burden; Young Adult	2011
Defining cure for esophageal cancer: analysis of actual 5-year survivors following esophagectomy. Annals of surgical oncology, 2011, Volume: 18, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Epirubicin; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Survival Rate; Survivors; Treatment Outcome	2011
Exclusive alternating chemotherapy and radiotherapy in nonmetastatic inflammatory breast cancer: 20 years of follow-up. International journal of radiation oncology, biology, physics, 2012, Feb-01, Volume: 82, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachial Plexus Neuropathies; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Combined Modality Therapy; Cyclophosphamide; Dose Fractionation, Radiation; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fibrosis; Fluorouracil; Follow-Up Studies; Heart; Humans; Inflammatory Breast Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Radiation Injuries; Radiation Pneumonitis; Survival Rate; Tamoxifen; Time Factors; Vincristine	2012
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: a prospective cohort study. European journal of radiology, 2012, Volume: 81, Issue:6 Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Disease Progression; Epirubicin; Ethiodized Oil; Female; Humans; Liver Function Tests; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Patient Selection; Prospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome	2012
Adjuvant chemolipiodolization reduces early recurrence derived from intrahepatic metastasis of hepatocellular carcinoma after hepatectomy. Annals of surgical oncology, 2011, Volume: 18, Issue:13 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Case-Control Studies; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Combined Modality Therapy; Epirubicin; Ethiodized Oil; Female; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies	2011
Previous chemoembolization response after transcatheter arterial chemoembolization (TACE) can predict the anti-tumor effect of subsequent TACE with miriplatin in patients with recurrent hepatocellular carcinoma. Oncology, 2011, Volume: 80, Issue:3-4 Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Epirubicin; Ethiodized Oil; Female; Humans; Injections, Intra-Arterial; Liver Neoplasms; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Organoplatinum Compounds; Retrospective Studies; Treatment Outcome	2011
Feasibility and safety of weekly sequential epirubicin-paclitaxel as adjuvant treatment for operable breast cancer patients older than 70 years. Clinical breast cancer, 2011, Volume: 11, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Epirubicin; Feasibility Studies; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prospective Studies; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Treatment Outcome	2011
Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer. European urology, 2011, Volume: 60, Issue:4 Topics: Aged; Antibiotics, Antineoplastic; Carcinoma; Combined Modality Therapy; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Risk Factors; Sex Factors; Smoking; Treatment Outcome; Urinary Bladder Neoplasms; Urologic Surgical Procedures	2011
Epirubicin and ifosfamide in relapsed or refractory small cell lung cancer patients. Lung cancer (Amsterdam, Netherlands), 2012, Volume: 75, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Epirubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local	2012
Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma. Japanese journal of radiology, 2012, Volume: 30, Issue:3 Topics: Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Organoplatinum Compounds; Statistics, Nonparametric; Treatment Outcome	2012
Prognostic significance of intraoperative chemotherapy and extensive lymphadenectomy in patients with node-negative gastric cancer. Journal of surgical oncology, 2012, Mar-15, Volume: 105, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Gastrectomy; Humans; Intraoperative Period; Leucovorin; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate	2012
Clinical correlates of 'BRCAness' in triple-negative breast cancer of patients receiving adjuvant chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Taxoids; Treatment Outcome; Young Adult	2012
Failure event types and prognostic factors after node-positive breast cancer in patients treated by adjuvant chemotherapy: impact on follow-up. Bulletin du cancer, 2012, Volume: 99, Issue:6 Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Melphalan; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prognosis; Randomized Controlled Trials as Topic; Taxoids; Treatment Failure	2012
Transcatheter arterial infusion chemotherapy prior to radiofrequency thermal ablation for single hepatocellular carcinoma reduces the risk of intrahepatic distant recurrence. International journal of oncology, 2012, Volume: 41, Issue:3 Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Chemotherapy, Adjuvant; Epirubicin; Ethiodized Oil; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Mitomycin; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome	2012
Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Epirubicin; Extremities; Female; Humans; Ifosfamide; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Proportional Hazards Models; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms; Surgical Procedures, Operative; Thoracic Neoplasms; Torso; Treatment Outcome; Young Adult	2013
Cigarette smoking status at diagnosis and recurrence in intermediate-risk non-muscle-invasive bladder carcinoma. Urology, 2013, Volume: 81, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma; Combined Modality Therapy; Cystectomy; Disease-Free Survival; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Proportional Hazards Models; Risk Factors; Smoking; Time Factors; Urinary Bladder Neoplasms	2013
Adjuvant concurrent chemoradiation using intensity-modulated radiotherapy and simultaneous integrated boost for resected high-risk adenocarcinoma of the distal esophagus and gastro-esophageal junction. Radiation oncology (London, England), 2013, Feb-11, Volume: 8 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organs at Risk; Prognosis; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate	2013
Efficacy of a primary chemotherapy regimen combining vinorelbine, epirubicin, and methotrexate (VEM) as neoadjuvant treatment in 89 patients with operable breast cancer. The oncologist, 2002, Volume: 7, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Epirubicin; Female; Humans; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Treatment Outcome; Vinblastine; Vinorelbine	2002
[A case report of hepatocellular carcinoma with portal thrombus responding to hepatic arterial infusion chemo-lipiodolization]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:12 Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Humans; Iodized Oil; Liver Neoplasms; Male; Mitomycin; Neoplasm Recurrence, Local; Portal Vein; Thrombosis	2002
Increased expression of BRCA1 mRNA predicts favorable response to anthracycline-containing chemotherapy in breast cancers. Breast cancer research and treatment, 2003, Volume: 78, Issue:1 Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Gene Expression; Genes, BRCA1; Genes, BRCA2; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests	2003
Sebaceous carcinoma of the vulva. BJOG : an international journal of obstetrics and gynaecology, 2003, Volume: 110, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Epirubicin; Female; Fluorouracil; Humans; Laparotomy; Middle Aged; Neoplasm Recurrence, Local; Sebaceous Gland Neoplasms; Tomography, X-Ray Computed; Vulvar Neoplasms	2003
[Malignant priapism as a sign of a recurrent prostate cancer. Differential diagnosis of induratio penis plastica]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2003, Volume: 54, Issue:6 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Diagnosis, Differential; Drug Therapy, Combination; Epirubicin; Estramustine; Flutamide; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Orchiectomy; Palliative Care; Penile Induration; Penile Neoplasms; Priapism; Prostatic Neoplasms; Time Factors	2003
Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation. Head & neck, 2003, Volume: 25, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blindness; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cytarabine; Epirubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Nasal Cavity; Necrosis; Neoplasm Recurrence, Local; Nose Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Salvage Therapy; Spinal Cord Neoplasms; Survival Analysis	2003
Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma. Journal of surgical oncology, 2003, Volume: 84, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Drug Screening Assays, Antitumor; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Survival Analysis	2003
[Cryoimmunological therapy with local injection of OK-432 against advance or recurrent breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:11 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cryosurgery; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Injections, Intralesional; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Picibanil; Taxoids	2003
15-year experience on intravesical therapy of T1G3 urinary bladder cancer: a conservative approach. Japanese journal of clinical oncology, 2004, Volume: 34, Issue:4 Topics: Administration, Intravesical; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; BCG Vaccine; Carcinoma, Transitional Cell; Disease Progression; Doxorubicin; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Survival Rate; Urinary Bladder Neoplasms	2004
Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB. Oncology reports, 2004, Volume: 11, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Survival Rate	2004
A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix. International journal of clinical oncology, 2004, Volume: 9, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Radiotherapy, Adjuvant; Statistics as Topic; Treatment Outcome; Uterine Cervical Neoplasms; Women's Health	2004
Epirubicin carboplatin and 5-fluorouracil (ECarboF) chemotherapy in metastatic hormone refractory prostate cancer. British journal of cancer, 2004, Oct-18, Volume: 91, Issue:8 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Epirubicin; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Prostate-Specific Antigen; Prostatic Neoplasms; Soft Tissue Neoplasms; Survival Rate	2004
Cost-effectiveness analysis of breast cancer adjuvant treatment: FEC 50 versus FEC 100 (FASG05 study). Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cohort Studies; Cost-Benefit Analysis; Cyclophosphamide; Drug Costs; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies	2005
[Follicular dendritic cell sarcoma]. Ugeskrift for laeger, 2005, May-02, Volume: 167, Issue:18 Topics: Abdominal Neoplasms; Adult; Antibiotics, Antineoplastic; Dendritic Cells, Follicular; Epirubicin; Humans; Liver Neoplasms; Liver Transplantation; Male; Neoplasm Recurrence, Local; Sarcoma	2005
[Invasive bladder cancer recurrenced 5 years after complete response status by chemotherapy and radiotherapy: a case report]. Hinyokika kiyo. Acta urologica Japonica, 2005, Volume: 51, Issue:11 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Epirubicin; Humans; Neoplasm Recurrence, Local; Remission Induction; Time Factors; Urinary Bladder Neoplasms	2005
Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2006, Volume: 182, Issue:1 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Breast; Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Lobular; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Dose Fractionation, Radiation; Doxorubicin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Risk Factors; Taxoids; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2006
Watchful waiting for low-grade Ta bladder tumours: the idea would have been unacceptable 30 years ago, but nowadays we are highly interested in the results of this study exploring it. European urology, 2006, Volume: 49, Issue:2 Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Carcinoma, Papillary; Epirubicin; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Randomized Controlled Trials as Topic; Transurethral Resection of Prostate; Urinary Bladder Neoplasms; Urothelium	2006
[Evaluation of transcatheter arterial chemoembolization in the prevention of postoperative recurrence in 1630 patients with hepatocellular carcinoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2005, Volume: 27, Issue:10 Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Postoperative Period	2005
Conservative treatment of high grade superficial bladder tumours. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2005, Volume: 77, Issue:4 Topics: Adjuvants, Immunologic; Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma, Transitional Cell; Epirubicin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Urinary Bladder Neoplasms	2005
Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival. Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Mar-01, Volume: 12, Issue:5 Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Neoplasm; Epirubicin; Female; Fluorouracil; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Proto-Oncogene Mas; Receptor, ErbB-2; Stereoisomerism	2006
Recurrent superior mediastinal primary hemangiopericytoma 23 years after the complete initial excision: a case report. Acta medica Okayama, 2006, Volume: 60, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Epirubicin; Fatal Outcome; Hemangiopericytoma; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Time Factors	2006
[Superficial bladder carcinoma -- trend of less aggressive therapies]. Aktuelle Urologie, 2006, Volume: 37, Issue:4 Topics: Antibiotics, Antineoplastic; Carcinoma, Papillary; Carcinoma, Transitional Cell; Cystoscopy; Epirubicin; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Papilloma; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Urinary Bladder Neoplasms	2006
Ipsilateral breast tumor reappearance in patients treated with conservative surgery after primary chemotherapy. The role of surgical margins on outcome. Journal of surgical oncology, 2006, Oct-01, Volume: 94, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy, Modified Radical; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Reoperation; Survival Rate; Treatment Outcome	2006
Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma? Pediatric blood & cancer, 2007, Volume: 49, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infection Control; Kaplan-Meier Estimate; Melphalan; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Postoperative Care; Retrospective Studies; Risk; Salvage Therapy; Sarcoma, Ewing; Topotecan; Transplantation Conditioning; Transplantation, Autologous; Treatment Failure; Vincristine	2007
Re-occurrence of the CD20 molecule expression subsequent to CD20-negative relapse in diffuse large B-cell lymphoma. Haematologica, 2007, Volume: 92, Issue:1 Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Fatal Outcome; Gene Expression Regulation, Neoplastic; Humans; Immunologic Factors; Immunophenotyping; Immunotherapy; Lymphatic Irradiation; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Recurrence, Local; Prednisone; Rituximab; Stomach Neoplasms; Vincristine	2007
An increase in cell number at completion of therapy may develop as an indicator of early relapse: quantification of circulating epithelial tumor cells (CETC) for monitoring of adjuvant therapy in breast cancer. Journal of cancer research and clinical oncology, 2008, Volume: 134, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Cell Count; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Epirubicin; Epithelial Cells; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Prognosis; Remission Induction; Survival Rate; Tamoxifen; Taxoids	2008
Prospective cohort comparison of neoadjuvant chemoradiotherapy versus chemotherapy in patients with oesophageal cancer. The British journal of surgery, 2007, Volume: 94, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome	2007
Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer. British journal of cancer, 2007, Oct-22, Volume: 97, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Taxoids	2007
Prognostic factors in patients treated with taxane-based chemotherapy for recurrent or metastatic endometrial cancer: proposal for a new prognostic model. Gynecologic oncology, 2008, Volume: 108, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Endometrial Neoplasms; Epirubicin; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Topotecan	2008
Pathological lymph node involvement at surgery is a significant predictive factor of recurrence in locally advanced breast cancer treated with concomitant epirubicin-docetaxel neoadjuvant chemotherapy: a cohort study. Breast cancer (Tokyo, Japan), 2009, Volume: 16, Issue:1 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cohort Studies; Disease-Free Survival; Docetaxel; Epirubicin; Female; Humans; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Retrospective Studies; Taxoids	2009
[Effects of 4'-Epi-adriamycin, THP-adriamycin and mitoxantrone on patients with advanced and recurrent breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1984, Volume: 11, Issue:8 Topics: Adult; Aged; Alopecia; Anthraquinones; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Middle Aged; Mitoxantrone; Nausea; Neoplasm Recurrence, Local; Vomiting	1984
Phase II trial of 4'-epi-doxorubicin in metastatic colorectal carcinoma. Investigational new drugs, 1984, Volume: 2, Issue:4 Topics: Aged; Antibiotics, Antineoplastic; Colonic Neoplasms; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Rectal Neoplasms; Sigmoid Neoplasms	1984
Intensive chemotherapy with high-dose epirubicin every 2 weeks and prophylactic administration of filgrastim in advanced breast cancer. European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; Epirubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neoplasm Recurrence, Local; Patient Compliance; Recombinant Proteins; Time Factors; Treatment Outcome	1994
Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast. Journal of the American College of Surgeons, 1995, Volume: 181, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy, Segmental; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Preoperative Care; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Remission Induction	1995
Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma. American journal of surgery, 1995, Volume: 169, Issue:4 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Disease-Free Survival; Epirubicin; Feasibility Studies; Female; Fluorouracil; Hepatectomy; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prospective Studies; Survival Rate; Tegafur; Uracil	1995
Undifferentiated (embryonal) sarcoma of the liver in an adult patient with metastasis of the heart and brain. The Clinical investigator, 1994, Volume: 72, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Epirubicin; Fatal Outcome; Female; Heart Neoplasms; Humans; Ifosfamide; Liver Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Pericardium; Ultrasonography	1994
Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm. Cancer, 1994, Aug-15, Volume: 74, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cobalt Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy, Modified Radical; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Survival Rate; Tamoxifen; Treatment Failure; Vindesine	1994
Trial with bacillus Calmette-Guérin and epirubicin combination in the prophylaxis of superficial bladder cancer. Urologia internationalis, 1994, Volume: 52, Issue:2 Topics: Administration, Intravesical; Adult; Aged; BCG Vaccine; Carcinoma, Transitional Cell; Combined Modality Therapy; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	1994
[Intra-arterial infusion chemotherapy for recurrent breast cancer via an implantable system]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Drug Administration Schedule; Epirubicin; Female; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Middle Aged; Neoplasm Recurrence, Local; Quality of Life	1993
Natural killer cell activity and progression-free survival in ovarian cancer. Gynecologic and obstetric investigation, 1993, Volume: 35, Issue:2 Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cystadenoma; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Endometriosis; Epirubicin; Female; Follow-Up Studies; Humans; Killer Cells, Natural; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis	1993
[Long-term results of chemoembolization of primary liver cancer with epirubicin-lipiodol]. Helvetica chirurgica acta, 1993, Volume: 59, Issue:4 Topics: Adenoma, Bile Duct; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Follow-Up Studies; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects	1993
Response to chemotherapy after relapse in patients with or without previous adjuvant chemotherapy for breast cancer. The French Epirubicin Study Group. Cancer treatment reviews, 1993, Volume: 19 Suppl B Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Survival Rate; Treatment Outcome	1993
[Transitional carcinoma of the bladder at the T1G3 stage: personal experience]. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 1996, Volume: 68, Issue:1 Topics: Antibiotics, Antineoplastic; BCG Vaccine; Biopsy; Carcinoma, Transitional Cell; Combined Modality Therapy; Endoscopy; Epirubicin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms	1996
[T1G3 bladder tumors: 5 years later]. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 1996, Volume: 68, Issue:1 Topics: Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystectomy; Disease-Free Survival; Endoscopy; Epirubicin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms	1996
Conservative management of stage T2 or T3a bladder cancer with deep transurethral resection followed by four cycles of chemotherapy. British journal of urology, 1996, Volume: 78, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Epirubicin; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine	1996
[The efficacy of ATP sensitivity assay on intravesical prophylactic instillation for superficial bladder cancer]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1996, Volume: 87, Issue:12 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Doxorubicin; Drug Screening Assays, Antitumor; Epirubicin; Female; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	1996
[A case of recurrent gallbladder cancer with marked response to arterial infusion chemotherapy and transarterial embolization]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cholecystectomy; Cisplatin; Drug Administration Schedule; Embolization, Therapeutic; Epirubicin; Fluorouracil; Gallbladder Neoplasms; Hepatic Artery; Humans; Infusions, Intra-Arterial; Lymph Node Excision; Male; Middle Aged; Neoplasm Recurrence, Local	1997
Role of P-glycoprotein in chemoresistant superficial bladder tumours. European urology, 1997, Volume: 31, Issue:2 Topics: Administration, Intravesical; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Carcinoma, Transitional Cell; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Urinary Bladder Neoplasms	1997
[Preliminary results of conservative combination radiotherapy and chemotherapy in early stages of Hodgkin's disease]. Polskie Archiwum Medycyny Wewnetrznej, 1996, Volume: 96, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Epirubicin; Female; Hodgkin Disease; Humans; Incidence; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Radiation Dosage; Remission Induction; Vinblastine	1996
Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma. Seminars in oncology, 1997, Volume: 24, Issue:2 Suppl 6 Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Ethanol; Female; Gelatin Sponge, Absorbable; Humans; Injections, Intralesional; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Rate	1997
CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma. American journal of clinical oncology, 1997, Volume: 20, Issue:4 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryonic Antigen; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Female; Humans; Incidence; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Palliative Care; Prognosis; Prospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Treatment Outcome	1997
[High-dosage chemotherapy and autologous transplant of hematopoietic germ cells from peripheral blood in high-risk recurrence carcinoma of the breast (with >= or 10 involved axillary nodes at diagnosis) Preliminary results of the Solti 9301 cooperative st Sangre, 1997, Volume: 42 Suppl 1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Thiotepa; Transplantation, Autologous	1997
Four years experience of primary intra-arterial chemotherapy (PIAC) for locally advanced and recurrent breast cancer. Minerva chirurgica, 1997, Volume: 52, Issue:9 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Breast Neoplasms; Breast Neoplasms, Male; Chemotherapy, Adjuvant; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mitomycins; Neoplasm Recurrence, Local; Time Factors	1997
Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional cell bladder tumours. British journal of urology, 1997, Volume: 80, Issue:6 Topics: Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Epirubicin; Extravasation of Diagnostic and Therapeutic Materials; Humans; Neoplasm Recurrence, Local; Urinary Bladder; Urinary Bladder Neoplasms	1997
Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long-term survival rate. European radiology, 1998, Volume: 8, Issue:3 Topics: Actuarial Analysis; Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheterization, Peripheral; Chemoembolization, Therapeutic; Disease Progression; Epirubicin; Ethanol; Female; Follow-Up Studies; Humans; Injections, Intralesional; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Survival Rate; Tomography, X-Ray Computed	1998
[Arterial infusion of SMANCS for multiple recurrent tumors after hepatic resection]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Embolization, Therapeutic; Epirubicin; Female; Hepatectomy; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Maleic Anhydrides; Middle Aged; Nausea; Neoplasm Recurrence, Local; Polystyrenes; Zinostatin	1998
Bladder cancer recurrence by implantation of exfoliated cells: is gamma-linolenic acid an effective tumoricidal agent? British journal of urology, 1998, Volume: 82, Issue:1 Topics: Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Cell Adhesion; Drug Resistance, Neoplasm; Epirubicin; gamma-Linolenic Acid; Humans; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Seeding; Serum Albumin; Tumor Cells, Cultured; Tumor Stem Cell Assay; Urinary Bladder Neoplasms; Water	1998
[Intra-arterial infusion chemotherapy for unresectable or recurrent breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Catheters, Indwelling; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Neoplasm Recurrence, Local	1998
[Intra-arterial chemotherapy to improve quality of life in cases of unresectable advanced or recurrent breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:9 Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Lymphatic Metastasis; Mammary Arteries; Neoplasm Recurrence, Local; Quality of Life; Subclavian Artery	1998
Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide: prognostic and therapeutic implications. Cancer, 1998, Sep-01, Volume: 83, Issue:5 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Epirubicin; Female; Fluorouracil; Humans; Lymph Node Excision; Mastectomy, Radical; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Tamoxifen; Treatment Outcome	1998
Long term results of surgery and chemotherapy in small cell lung cancer. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 1998, Volume: 14, Issue:4 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Longitudinal Studies; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Postoperative Complications; Prospective Studies; Radiotherapy, Adjuvant; Survival Rate; Vincristine	1998
[Intravesical instillation of epirubicin in the prophylactic treatment of recurrent superficial bladder cancer]. Hinyokika kiyo. Acta urologica Japonica, 1998, Volume: 44, Issue:12 Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cystectomy; Epirubicin; Humans; Neoplasm Recurrence, Local; Retrospective Studies; Urinary Bladder Neoplasms	1998
[Neoadjuvant chemotherapy FEC-HD in locally advanced breast cancer]. Bulletin du cancer, 1999, Volume: 86, Issue:2 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Thrombocytopenia	1999
[Primary lymphoma of the thyroid with contralateral recurrence--case report]. Wiener klinische Wochenschrift, 1999, Apr-23, Volume: 111, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Citrates; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Female; Gallium; Gallium Radioisotopes; Humans; Ifosfamide; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Radiopharmaceuticals; Remission Induction; Technetium; Thallium; Thyroid Neoplasms; Thyroidectomy; Vincristine	1999
Primary neuroendocrine small cell carcinoma of the breast. Archives of pathology & laboratory medicine, 2000, Volume: 124, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy, Needle; Breast Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy	2000
[Transcatheter arterial chemo-embolization using degradable starch microspheres (DSM) markedly effective for post-hepatectomy intra-hepatic recurrence in a patient with cholangioma]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:12 Topics: Aged; Antibiotics, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cholangiocarcinoma; Epirubicin; Hepatectomy; Humans; Liver Neoplasms; Male; Microspheres; Mitomycin; Neoplasm Recurrence, Local; Postoperative Period; Starch	2000
Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer. Gynecologic oncology, 2000, Volume: 79, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome	2000
Feasibility and long-term results of autologous PBSC transplantation in recurrent undifferentiated nasopharyngeal carcinoma. Head & neck, 2001, Volume: 23, Issue:9 Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Transplantation, Autologous	2001
Locally recurrent adenoid cystic carcinoma of the left antrum: response to epirubicin, cisplatin and 5-fluorouracil. Clinical oncology (Royal College of Radiologists (Great Britain)), 2001, Volume: 13, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Cisplatin; Disease-Free Survival; Epirubicin; Fluorouracil; Humans; Magnetic Resonance Imaging; Male; Maxillary Sinus; Middle Aged; Neoplasm Recurrence, Local; Paranasal Sinus Neoplasms; Treatment Outcome	2001
Frequency of positive biopsies after visual disappearance of superficial bladder cancer marker lesions. European urology, 2001, Volume: 40, Issue:5 Topics: Administration, Intravesical; Antibiotics, Antineoplastic; BCG Vaccine; Biopsy; Carcinoma, Transitional Cell; Clinical Protocols; Clinical Trials, Phase II as Topic; Cystoscopy; Epirubicin; Humans; Mitomycin; Neoplasm Recurrence, Local; Neoplasm, Residual; Urinary Bladder Neoplasms	2001
Intravesical epirubicin treatment following TUR in superficial bladder tumours. Archivos espanoles de urologia, 2001, Volume: 54, Issue:10 Topics: Administration, Intravesical; Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Urethra; Urinary Bladder Neoplasms; Urologic Surgical Procedures	2001
High-dose adjuvant chemotherapy for patients with high-risk breast cancer: efficacy is still an open question. Clinical breast cancer, 2000, Volume: 1, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Clinical Trials as Topic; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lymph Nodes; Middle Aged; Neoplasm Recurrence, Local; Survival Rate; Thiotepa	2000
Prediction of chemotherapeutic response by collagen gel droplet embedded culture-drug sensitivity test in human breast cancers. International journal of cancer, 2002, Mar-20, Volume: 98, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Collagen; Cyclophosphamide; Docetaxel; Drug Screening Assays, Antitumor; Epirubicin; Female; Gels; Humans; Immunoenzyme Techniques; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Predictive Value of Tests; Taxoids	2002
Metastatic astrocytoma in the parotid. Cytopathology : official journal of the British Society for Clinical Cytology, 2002, Volume: 13, Issue:3 Topics: Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Biopsy, Needle; Brain Neoplasms; Cyclophosphamide; Epirubicin; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Parotid Neoplasms	2002
[Retrospective survey of pharmacologic tolerance in the prevention of neoplastic recurrence of superficial urothelioma]. Archivio italiano di urologia, nefrologia, andrologia : organo ufficiale dell'Associazione per la ricerca in urologia = Urological, nephrological, and andrological sciences, 1992, Volume: 64, Issue:4 Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Humans; Interferons; Mitomycin; Neoplasm Recurrence, Local; Retrospective Studies; Urinary Bladder Neoplasms	1992
Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy carboplatin, etoposide, and epirubicin. Thorax, 1992, Volume: 47, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Tomography, X-Ray Computed	1992
[Chemoembolization in the therapy of hepatocarcinoma. A 3-year experience]. La Radiologia medica, 1992, Volume: 84, Issue:5 Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Epirubicin; Female; Humans; Iodized Oil; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Care; Preoperative Care	1992
The use of adriamycin and its derivatives in the treatment of prostatic cancer. Cancer chemotherapy and pharmacology, 1992, Volume: 30 Suppl Topics: Aged; Androgens; Antineoplastic Combined Chemotherapy Protocols; Cell Death; Cellular Senescence; Clinical Trials as Topic; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Humans; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms	1992
[A pharmacokinetic study of intra-arterial chemotherapy for prophylactic treatment of liver metastasis after hepatectomy for liver cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:10 Suppl Topics: Chemotherapy, Adjuvant; Doxorubicin; Epirubicin; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Liver; Liver Neoplasms; Mitomycin; Neoplasm Recurrence, Local; Postoperative Care	1992
[Intra-arterial infusion chemotherapy in locally recurrent breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:10 Suppl Topics: Adult; Breast Neoplasms; Drug Administration Schedule; Epirubicin; Female; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Middle Aged; Neoplasm Recurrence, Local	1992
[Cancer chemotherapy for recurrence of breast cancer employing implantable system via right internal mammary vein]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:10 Suppl Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Catheters, Indwelling; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Medroxyprogesterone; Middle Aged; Neoplasm Recurrence, Local; Subclavian Vein; Vena Cava, Superior	1992
Intra-abdominal panniculitis can mimic recurrent stomach carcinoma. Clinical oncology (Royal College of Radiologists (Great Britain)), 1992, Volume: 4, Issue:3 Topics: Abdomen; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Diagnosis, Differential; Epirubicin; Fat Necrosis; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Panniculitis; Stomach Neoplasms	1992
Epirubicin: a phase II study in recurrent small-cell lung cancer. Cancer chemotherapy and pharmacology, 1991, Volume: 28, Issue:3 Topics: Aged; Carcinoma, Small Cell; Drug Evaluation; Epirubicin; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Remission Induction; Time Factors	1991
Intravesical sequential combination of epirubicin and interferon alpha-2b in patients affected by superficial transitional cell carcinoma of the bladder. Results of a pilot study at Palermo University and proposal of a basic research. Progress in clinical and biological research, 1991, Volume: 370 Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Drug Administration Schedule; Epirubicin; Follow-Up Studies; Humans; Interferon alpha-2; Interferon-alpha; Neoplasm Recurrence, Local; Pilot Projects; Recombinant Proteins; Urinary Bladder Neoplasms	1991
Phase 1/2 study of intravesical epirubicin in patients with carcinoma in situ of the bladder. The Journal of urology, 1991, Volume: 146, Issue:6 Topics: Administration, Intravesical; Carcinoma in Situ; Drug Evaluation; Epirubicin; Humans; Neoplasm Recurrence, Local; Survival Rate; Urinary Bladder Neoplasms	1991
Targeted therapy for recurrent breast carcinoma with regional 'Lipiodol'/epirubicin infusion. Lancet (London, England), 1990, Dec-01, Volume: 336, Issue:8727 Topics: Aged; Breast Neoplasms; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Iodized Oil; Middle Aged; Neoplasm Recurrence, Local	1990
Nasopharyngeal carcinoma with bone marrow metastasis. American journal of clinical oncology, 1991, Volume: 14, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma; Cisplatin; Combined Modality Therapy; Epirubicin; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Radiotherapy Dosage; Survival Rate	1991
Malignant fibrous histiocytoma of the fallopian tube. British journal of obstetrics and gynaecology, 1990, Volume: 97, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Fallopian Tube Neoplasms; Female; Histiocytoma, Benign Fibrous; Humans; Ifosfamide; Mesna; Middle Aged; Neoplasm Recurrence, Local	1990
[Nonspecific immunotherapy with BCG vaccine in bladder tumors]. Khirurgiia, 1990, Volume: 43, Issue:1 Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Epirubicin; Humans; Immunotherapy; Injections, Intradermal; Neoplasm Recurrence, Local; Postoperative Care; Urinary Bladder Neoplasms	1990
Cisplatin, epirubicin and 5-fluorouracil combination chemotherapy for recurrent carcinoma of the salivary gland. Tumori, 1989, Jun-30, Volume: 75, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Adenoid Cystic; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Salivary Gland Neoplasms	1989
Phase II study of combination 4'-epidoxorubicin and mitomycin C in recurrent epithelial ovarian cancer. Cancer chemotherapy and pharmacology, 1989, Volume: 23, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Epirubicin; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Ovarian Neoplasms	1989
Sequential alternating medroxyprogesterone acetate and epirubicin in the treatment of advanced breast cancer. The Australian and New Zealand journal of surgery, 1989, Volume: 59, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Delayed-Action Preparations; Drug Evaluation; Epirubicin; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local	1989
[Adjuvant chemotherapy with biocisplatin, methotrexate and biocarbazine in advanced bladder tumors]. Khirurgiia, 1989, Volume: 42, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Dacarbazine; Drug Evaluation; Epirubicin; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Urinary Bladder Neoplasms; Vinblastine	1989
Epirubicin in treatment and recurrence prophylaxis of patients with superficial bladder cancer. Progress in clinical and biological research, 1989, Volume: 303 Topics: Administration, Intravesical; Carcinoma in Situ; Carcinoma, Papillary; Combined Modality Therapy; Epirubicin; Humans; Instillation, Drug; Neoplasm Recurrence, Local; Prognosis; Urinary Bladder; Urinary Bladder Neoplasms	1989
4-epidoxorubicin in recurrent cervical cancer. Cancer, 1989, Apr-01, Volume: 63, Issue:7 Topics: Adult; Carcinoma, Squamous Cell; Epirubicin; Female; Heart Diseases; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms	1989
[Combination chemotherapy using low-dose epirubicin and vindesine in patients with metastatic breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:4 Pt 1 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Tamoxifen; Tegafur; Uracil; Vindesine	1988
5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)". Onkologie, 1987, Volume: 10, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Drug Evaluation; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Neoplasm Recurrence, Local; Stomach Neoplasms	1987
[Experiences with PAC and PEC polychemotherapy in the treatment of advanced and recurrent breast cancers]. Zentralblatt fur Gynakologie, 1988, Volume: 110, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Lymph Node Excision; Mastectomy; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local	1988